WO2019066068A1 - 水中油型乳化組成物、並びに、これを含む食品及び飲料 - Google Patents
水中油型乳化組成物、並びに、これを含む食品及び飲料 Download PDFInfo
- Publication number
- WO2019066068A1 WO2019066068A1 PCT/JP2018/036573 JP2018036573W WO2019066068A1 WO 2019066068 A1 WO2019066068 A1 WO 2019066068A1 JP 2018036573 W JP2018036573 W JP 2018036573W WO 2019066068 A1 WO2019066068 A1 WO 2019066068A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- oil
- mass
- water
- emulsion composition
- water emulsion
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 307
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 74
- 235000013305 food Nutrition 0.000 title claims description 29
- 235000013361 beverage Nutrition 0.000 title claims description 26
- 229940022405 astaxanthin Drugs 0.000 claims abstract description 105
- 239000001168 astaxanthin Substances 0.000 claims abstract description 105
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims abstract description 104
- 235000013793 astaxanthin Nutrition 0.000 claims abstract description 104
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims abstract description 103
- -1 sucrose fatty acid ester Chemical class 0.000 claims abstract description 103
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 84
- 239000000194 fatty acid Substances 0.000 claims abstract description 84
- 229930195729 fatty acid Natural products 0.000 claims abstract description 84
- 239000000284 extract Substances 0.000 claims abstract description 68
- 239000005720 sucrose Substances 0.000 claims abstract description 48
- 229930006000 Sucrose Natural products 0.000 claims abstract description 46
- 239000000787 lecithin Substances 0.000 claims abstract description 37
- 235000010445 lecithin Nutrition 0.000 claims abstract description 37
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 36
- 229940067606 lecithin Drugs 0.000 claims abstract description 36
- 150000008442 polyphenolic compounds Chemical class 0.000 claims abstract description 21
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 21
- 241001122767 Theaceae Species 0.000 claims abstract 14
- 239000007764 o/w emulsion Substances 0.000 claims description 219
- 239000003921 oil Substances 0.000 claims description 51
- 239000000839 emulsion Substances 0.000 claims description 40
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 32
- 235000011187 glycerol Nutrition 0.000 claims description 16
- 239000008346 aqueous phase Substances 0.000 claims description 15
- 239000003995 emulsifying agent Substances 0.000 claims description 14
- 241001465754 Metazoa Species 0.000 claims description 7
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 5
- 235000013373 food additive Nutrition 0.000 claims description 4
- 239000002778 food additive Substances 0.000 claims description 4
- 235000019871 vegetable fat Nutrition 0.000 claims description 4
- 244000269722 Thea sinensis Species 0.000 description 67
- 235000013616 tea Nutrition 0.000 description 63
- 235000019198 oils Nutrition 0.000 description 47
- 238000000034 method Methods 0.000 description 44
- 239000003963 antioxidant agent Substances 0.000 description 41
- 230000003078 antioxidant effect Effects 0.000 description 41
- 235000006708 antioxidants Nutrition 0.000 description 41
- 239000002245 particle Substances 0.000 description 31
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 30
- 238000002360 preparation method Methods 0.000 description 30
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 27
- SATICYYAWWYRAM-VNKDHWASSA-N (E,E)-hepta-2,4-dienal Chemical compound CC\C=C\C=C\C=O SATICYYAWWYRAM-VNKDHWASSA-N 0.000 description 26
- 239000012071 phase Substances 0.000 description 26
- 229920002472 Starch Polymers 0.000 description 23
- 150000002148 esters Chemical class 0.000 description 23
- 239000000126 substance Substances 0.000 description 23
- 235000019698 starch Nutrition 0.000 description 22
- 238000011156 evaluation Methods 0.000 description 21
- 239000008107 starch Substances 0.000 description 21
- 239000000796 flavoring agent Substances 0.000 description 20
- 239000007901 soft capsule Substances 0.000 description 20
- 239000000047 product Substances 0.000 description 19
- 125000004432 carbon atom Chemical group C* 0.000 description 17
- 235000019634 flavors Nutrition 0.000 description 17
- 239000002994 raw material Substances 0.000 description 17
- 239000006188 syrup Substances 0.000 description 17
- 235000020357 syrup Nutrition 0.000 description 17
- 238000004519 manufacturing process Methods 0.000 description 15
- 241000195493 Cryptophyta Species 0.000 description 14
- 241000168525 Haematococcus Species 0.000 description 14
- 150000001875 compounds Chemical class 0.000 description 14
- 150000004665 fatty acids Chemical class 0.000 description 14
- 150000003839 salts Chemical class 0.000 description 14
- 235000000346 sugar Nutrition 0.000 description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 235000010323 ascorbic acid Nutrition 0.000 description 12
- 239000011668 ascorbic acid Substances 0.000 description 12
- 229960005070 ascorbic acid Drugs 0.000 description 12
- 239000007788 liquid Substances 0.000 description 12
- 150000004671 saturated fatty acids Chemical class 0.000 description 12
- 108010010803 Gelatin Proteins 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 11
- 238000001035 drying Methods 0.000 description 11
- 238000004945 emulsification Methods 0.000 description 11
- 239000008273 gelatin Substances 0.000 description 11
- 229920000159 gelatin Polymers 0.000 description 11
- 235000019322 gelatine Nutrition 0.000 description 11
- 235000011852 gelatine desserts Nutrition 0.000 description 11
- 239000000049 pigment Substances 0.000 description 11
- 229930003427 Vitamin E Natural products 0.000 description 10
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 10
- 238000005259 measurement Methods 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- 229930003799 tocopherol Natural products 0.000 description 10
- 235000010384 tocopherol Nutrition 0.000 description 10
- 229960001295 tocopherol Drugs 0.000 description 10
- 239000011732 tocopherol Substances 0.000 description 10
- 150000004670 unsaturated fatty acids Chemical group 0.000 description 10
- 235000019165 vitamin E Nutrition 0.000 description 10
- 239000011709 vitamin E Substances 0.000 description 10
- 229940046009 vitamin E Drugs 0.000 description 10
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 10
- 150000000996 L-ascorbic acids Chemical class 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 238000009472 formulation Methods 0.000 description 8
- 238000001556 precipitation Methods 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- 150000005846 sugar alcohols Polymers 0.000 description 8
- ONAIRGOTKJCYEY-XXDXYRHBSA-N CCCCCCCCCCCCCCCCCC(O)=O.O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 Chemical compound CCCCCCCCCCCCCCCCCC(O)=O.O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ONAIRGOTKJCYEY-XXDXYRHBSA-N 0.000 description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 7
- 238000011088 calibration curve Methods 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 238000003860 storage Methods 0.000 description 7
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 7
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 6
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 150000004667 medium chain fatty acids Chemical class 0.000 description 6
- 239000004014 plasticizer Substances 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 238000002296 dynamic light scattering Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 5
- 235000003599 food sweetener Nutrition 0.000 description 5
- 229920001542 oligosaccharide Polymers 0.000 description 5
- 150000002482 oligosaccharides Chemical class 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 239000003765 sweetening agent Substances 0.000 description 5
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 4
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 235000006468 Thea sinensis Nutrition 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 4
- 230000001877 deodorizing effect Effects 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 229940030275 epigallocatechin gallate Drugs 0.000 description 4
- 235000019688 fish Nutrition 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 235000013402 health food Nutrition 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N n-hexadecanoic acid Natural products CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 238000010298 pulverizing process Methods 0.000 description 4
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000001694 spray drying Methods 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- 229960001727 tretinoin Drugs 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241000284156 Clerodendrum quadriloculare Species 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 241000239366 Euphausiacea Species 0.000 description 3
- 229930091371 Fructose Natural products 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 3
- 241000168517 Haematococcus lacustris Species 0.000 description 3
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 3
- 239000012901 Milli-Q water Substances 0.000 description 3
- 235000021314 Palmitic acid Nutrition 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 3
- 235000005487 catechin Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 230000001804 emulsifying effect Effects 0.000 description 3
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 3
- 230000001747 exhibiting effect Effects 0.000 description 3
- 235000013355 food flavoring agent Nutrition 0.000 description 3
- LVJJFMLUMNSUFN-UHFFFAOYSA-N gallocatechin gallate Natural products C1=C(O)C=C2OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C1OC(=O)C1=CC(O)=C(O)C(O)=C1 LVJJFMLUMNSUFN-UHFFFAOYSA-N 0.000 description 3
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 3
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 3
- 230000001771 impaired effect Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 238000000465 moulding Methods 0.000 description 3
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 229930002330 retinoic acid Natural products 0.000 description 3
- 229960000342 retinol acetate Drugs 0.000 description 3
- 235000019173 retinyl acetate Nutrition 0.000 description 3
- 239000011770 retinyl acetate Substances 0.000 description 3
- 239000012488 sample solution Substances 0.000 description 3
- 235000003441 saturated fatty acids Nutrition 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 235000010356 sorbitol Nutrition 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 3
- WMBWREPUVVBILR-GHTZIAJQSA-N (+)-gallocatechin gallate Chemical compound O([C@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-GHTZIAJQSA-N 0.000 description 2
- RYCNUMLMNKHWPZ-SNVBAGLBSA-N 1-acetyl-sn-glycero-3-phosphocholine Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C RYCNUMLMNKHWPZ-SNVBAGLBSA-N 0.000 description 2
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 2
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 2
- 239000005695 Ammonium acetate Substances 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000238424 Crustacea Species 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 229930184207 Polyphenon Natural products 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- 240000005499 Sasa Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- ONAIRGOTKJCYEY-UHFFFAOYSA-N Sucrose monostearate Chemical compound CCCCCCCCCCCCCCCCCC(O)=O.OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(CO)O1 ONAIRGOTKJCYEY-UHFFFAOYSA-N 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- GCSPRLPXTPMSTL-IBDNADADSA-N [(2s,3r,4s,5s,6r)-2-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)O[C@@]1([C@]2(CO)[C@H]([C@H](O)[C@@H](CO)O2)O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GCSPRLPXTPMSTL-IBDNADADSA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 235000019257 ammonium acetate Nutrition 0.000 description 2
- 229940043376 ammonium acetate Drugs 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 150000001514 astaxanthins Chemical class 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000020279 black tea Nutrition 0.000 description 2
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 150000001765 catechin Chemical class 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 235000005687 corn oil Nutrition 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000003631 expected effect Effects 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000008123 high-intensity sweetener Substances 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 229940070765 laurate Drugs 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 229940049964 oleate Drugs 0.000 description 2
- 235000020333 oolong tea Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 235000019629 palatability Nutrition 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 229960003471 retinol Drugs 0.000 description 2
- 235000020944 retinol Nutrition 0.000 description 2
- 239000011607 retinol Substances 0.000 description 2
- 229940108325 retinyl palmitate Drugs 0.000 description 2
- 235000019172 retinyl palmitate Nutrition 0.000 description 2
- 239000011769 retinyl palmitate Substances 0.000 description 2
- 229940092258 rosemary extract Drugs 0.000 description 2
- 235000020748 rosemary extract Nutrition 0.000 description 2
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 2
- 238000010008 shearing Methods 0.000 description 2
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 229910021642 ultra pure water Inorganic materials 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- XMOCLSLCDHWDHP-SWLSCSKDSA-N (+)-Epigallocatechin Natural products C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-SWLSCSKDSA-N 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- LSHVYAFMTMFKBA-PZJWPPBQSA-N (+)-catechin-3-O-gallate Chemical compound O([C@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-PZJWPPBQSA-N 0.000 description 1
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 1
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- LSHVYAFMTMFKBA-TZIWHRDSSA-N (-)-epicatechin-3-O-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-TZIWHRDSSA-N 0.000 description 1
- DBSABEYSGXPBTA-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O DBSABEYSGXPBTA-RXSVEWSESA-N 0.000 description 1
- ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 description 1
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- XOBOCRSRGDBOGH-UHFFFAOYSA-N 5-phenylnonan-5-ol Chemical compound CCCCC(O)(CCCC)C1=CC=CC=C1 XOBOCRSRGDBOGH-UHFFFAOYSA-N 0.000 description 1
- SERLAGPUMNYUCK-YJOKQAJESA-N 6-O-alpha-D-glucopyranosyl-D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-YJOKQAJESA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-araboascorbic acid Natural products OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- LSHVYAFMTMFKBA-UHFFFAOYSA-N ECG Natural products C=1C=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-UHFFFAOYSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- OEIJRRGCTVHYTH-UHFFFAOYSA-N Favan-3-ol Chemical compound OC1CC2=CC=CC=C2OC1C1=CC=CC=C1 OEIJRRGCTVHYTH-UHFFFAOYSA-N 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241000733385 Haematococcus capensis Species 0.000 description 1
- 241000500309 Haematococcus zimbabwiensis Species 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- FAIXYKHYOGVFKA-UHFFFAOYSA-N Kinetin Natural products N=1C=NC=2N=CNC=2C=1N(C)C1=CC=CO1 FAIXYKHYOGVFKA-UHFFFAOYSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- XJCCHWKNFMUJFE-CGQAXDJHSA-N Maltotriitol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O[C@@H]([C@H](O)[C@@H](O)CO)[C@H](O)CO)O[C@H](CO)[C@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 XJCCHWKNFMUJFE-CGQAXDJHSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- WTAYIFXKJBMZLY-XZABIIKCSA-N OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O Chemical compound OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O WTAYIFXKJBMZLY-XZABIIKCSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241001282110 Pagrus major Species 0.000 description 1
- 241001542817 Phaffia Species 0.000 description 1
- 102000015439 Phospholipases Human genes 0.000 description 1
- 108010064785 Phospholipases Proteins 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 239000004260 Potassium ascorbate Substances 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- ZPVGIKNDGJGLCO-VGAMQAOUSA-N [(2s,3r,4s,5s,6r)-2-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)O[C@@]1([C@]2(CO)[C@H]([C@H](O)[C@@H](CO)O2)O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O ZPVGIKNDGJGLCO-VGAMQAOUSA-N 0.000 description 1
- SZYSLWCAWVWFLT-UTGHZIEOSA-N [(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methyl octadecanoate Chemical compound O([C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@]1(COC(=O)CCCCCCCCCCCCCCCCC)O[C@H](CO)[C@@H](O)[C@@H]1O SZYSLWCAWVWFLT-UTGHZIEOSA-N 0.000 description 1
- UEYVMVXJVDAGBB-ZHBLIPIOSA-N [(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methyl tetradecanoate Chemical compound O([C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@]1(COC(=O)CCCCCCCCCCCCC)O[C@H](CO)[C@@H](O)[C@@H]1O UEYVMVXJVDAGBB-ZHBLIPIOSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940071097 ascorbyl phosphate Drugs 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- MQZIGYBFDRPAKN-UWFIBFSHSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-UWFIBFSHSA-N 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 238000004630 atomic force microscopy Methods 0.000 description 1
- 210000000467 autonomic pathway Anatomy 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- 235000010376 calcium ascorbate Nutrition 0.000 description 1
- 239000011692 calcium ascorbate Substances 0.000 description 1
- 229940047036 calcium ascorbate Drugs 0.000 description 1
- BLORRZQTHNGFTI-ZZMNMWMASA-L calcium-L-ascorbate Chemical compound [Ca+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] BLORRZQTHNGFTI-ZZMNMWMASA-L 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000007084 catalytic combustion reaction Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000000642 dynamic headspace extraction Methods 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 description 1
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- 235000010350 erythorbic acid Nutrition 0.000 description 1
- 239000004318 erythorbic acid Substances 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 229930182497 flavan-3-ol Natural products 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000020510 functional beverage Nutrition 0.000 description 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 1
- 150000003271 galactooligosaccharides Chemical class 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 108010025899 gelatin film Proteins 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 238000003988 headspace gas chromatography Methods 0.000 description 1
- 238000009532 heart rate measurement Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- SATICYYAWWYRAM-UHFFFAOYSA-N hepta-2,4-dienal Chemical compound CCC=CC=CC=O SATICYYAWWYRAM-UHFFFAOYSA-N 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 230000005934 immune activation Effects 0.000 description 1
- 150000002500 ions Chemical group 0.000 description 1
- 229940026239 isoascorbic acid Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- QANMHLXAZMSUEX-UHFFFAOYSA-N kinetin Chemical compound N=1C=NC=2N=CNC=2C=1NCC1=CC=CO1 QANMHLXAZMSUEX-UHFFFAOYSA-N 0.000 description 1
- 229960001669 kinetin Drugs 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 229940057059 monascus purpureus Drugs 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 239000008239 natural water Substances 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 238000000399 optical microscopy Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- YWCYJWYNSHTONE-UHFFFAOYSA-O oxido(oxonio)boron Chemical compound [OH2+][B][O-] YWCYJWYNSHTONE-UHFFFAOYSA-O 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001522 polyglycol ester Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 235000019275 potassium ascorbate Nutrition 0.000 description 1
- 229940017794 potassium ascorbate Drugs 0.000 description 1
- CONVKSGEGAVTMB-RXSVEWSESA-M potassium-L-ascorbate Chemical compound [K+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] CONVKSGEGAVTMB-RXSVEWSESA-M 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 239000011755 sodium-L-ascorbate Substances 0.000 description 1
- 235000019187 sodium-L-ascorbate Nutrition 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 238000001370 static light scattering Methods 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 150000004044 tetrasaccharides Chemical class 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/10—Foods or foodstuffs containing additives; Preparation or treatment thereof containing emulsifiers
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/214—Tea
Definitions
- the present disclosure relates to oil-in-water emulsified compositions, and foods and beverages containing the same.
- Astaxanthin attracts attention as a component having an "antioxidant action” that eliminates active oxygen, and has recently been widely distributed as a raw material for health food.
- Astaxanthin is a kind of natural carotenoid pigment and widely distributed in the natural world, and is abundantly contained in fish such as salmon and red sea bream, crustaceans such as crab, shrimp and krill, algae and the like.
- fish such as salmon and red sea bream
- crustaceans such as crab, shrimp and krill, algae and the like.
- astaxanthin when used as a food material, it has low solubility in water and therefore has poor digestibility and absorption, as well as defects such as a decrease in the palatability of goods due to a specific odor derived from the material.
- Japanese Patent No. 4163218 discloses a stable hematococcus alga pigment-containing emulsion composition which can be suitably used for various foods, is stable, has no odor, and can be stored for a long period of time.
- a Haematococcus alga pigment which is characterized by preparing an emulsion composition comprising an oil containing a coccus algae pigment, an emulsifier at least sufficient to emulsify the oil, and a tea extract and a hydrophilic medium.
- the present invention has prepared an emulsion for an astaxanthin-containing oil-in-water emulsion composition for food addition with high palatability with reduced unique odor derived from astaxanthin raw materials. Then, it turned out that emulsion stability becomes worse.
- one of the embodiments of the present invention has an object to provide an oil-in-water emulsion composition that suppresses odor derived from astaxanthin raw materials and is excellent in emulsion stability.
- An object of one of the embodiments of the present invention is to provide a food or beverage containing an oil-in-water emulsified composition which suppresses odor derived from a raw material of astaxanthin and which is excellent in emulsion stability.
- the present inventors include astaxanthin, an oily component, an enzyme-degraded lecithin, sucrose fatty acid ester, a water-soluble tea extract, and water, and the water-soluble tea extract is tea based on the total mass of the water-soluble tea extract. 20% by mass or more of polyphenol, the content of astaxanthin to the total mass of the oil-in-water emulsion composition is 0.1% to 20.0% by mass, and the water-soluble tea to the total mass of the oil-in-water emulsion composition It has been found that the above-mentioned problems can be solved by the oil-in-water emulsion composition wherein the content of the extract is more than 0% by mass and 2.0% by mass or less.
- a food comprising the oil-in-water emulsion composition according to any one of [1] to [12].
- a beverage comprising the oil-in-water emulsion composition according to any one of [1] to [12].
- an astaxanthin-containing oil-in-water emulsion composition which suppresses the odor derived from the raw material of astaxanthin and is excellent in the emulsion stability. Further, according to one embodiment of the present invention, there is provided a food or beverage containing an astaxanthin-containing oil-in-water emulsion composition which suppresses the odor derived from the raw material of astaxanthin and which is excellent in emulsion stability. it can.
- a numerical range indicated by using “to” means a range including numerical values described before and after “to” as the minimum value and the maximum value, respectively.
- the upper limit value or the lower limit value described in a certain numerical value range may be replaced with the upper limit value or the lower limit value of the other stepwise description numerical value range in the numerical value range described stepwise in the present disclosure.
- the upper limit value or the lower limit value described in a certain numerical range may be replaced with the value shown in the example.
- the amount of each component means the total amount of the plurality of substances present in the composition unless a plurality of substances corresponding to each component are present in the composition. Do. In the present disclosure, a combination of two or more preferred embodiments is a more preferred embodiment.
- HLB value refers to a commercially available product as a component, and when a commercially available product such as a catalog clearly shows the HLB value of the commercially available product. , The catalog, etc. adopt the values shown in the literature. If the component used is not a commercial product, or if it is commercially available but the HLB value is not clearly indicated in the literature such as a catalog, the Kawabe formula shown below is adopted as the HLB value in the present disclosure. Do.
- M w is the molecular weight of the hydrophilic group
- M 0 is the molecular weight of the hydrophobic group
- step is included in the term if the intended purpose of the step is achieved, even if it can not be distinguished clearly from the other steps, not only the independent step.
- water phase is used as a term for the "oil phase” regardless of the type of solvent.
- One embodiment of the present disclosure includes astaxanthin, an oily component, an enzyme-degraded lecithin, sucrose fatty acid ester, a water soluble tea extract, and water, wherein the water soluble tea extract is the total weight of the water soluble tea extract
- the tea polyphenol contains 20% by mass or more of tea polyphenol, the content of astaxanthin is 0.1% by mass to 20.0% by mass with respect to the total mass of the oil-in-water emulsion composition, and the whole of the oil-in-water emulsion composition
- An oil-in-water emulsion composition having a water-soluble tea extract content of more than 0% by mass and 20.0% by mass or less based on the mass may be simply referred to as "the oil-in-water emulsion composition of the present disclosure”.
- One of the embodiments of the present disclosure is a food or beverage containing the oil-in-water emulsion composition of the present disclosure (hereinafter, may simply be referred to as "the food of the present disclosure” or “the beverage of the present disclosure”). .
- the oil-in-water emulsion composition of the present disclosure comprises astaxanthin having a content of 0.1% by mass to 20.0% by mass with respect to the total mass of the oil-in-water emulsion composition, an oil component, and an enzyme-degraded lecithin
- the sucrose fatty acid ester and the total content of the oil-in-water emulsified composition have a content of more than 0% by mass and 20.0% or less, and 20 mass% of tea polyphenol with respect to the total mass of the water-soluble tea extract It is an oil-in-water type emulsion composition containing the water-soluble tea extract which contains% or more, and water.
- Astaxanthin attracts attention as a component having an "antioxidant action" that eliminates active oxygen. Further, astaxanthin is known to have various functions such as immune activation, fatigue recovery, balance adjustment of autonomic nerves, and is widely used as a raw material for health food and the like. However, it has become clear from the study of the inventor that the taste of the product may be reduced due to the odor derived from the astaxanthin raw material. Such a phenomenon tends to occur particularly when the food is formulated with higher concentrations of astaxanthin for the purpose of functional indication and the like.
- the odor is caused by containing a specific amount of astaxanthin, an oily component, an enzyme-degraded lecithin, a sucrose fatty acid ester, a specific amount of a water-soluble tea extract, and water. It is possible to provide an oil-in-water emulsion composition which is suppressed and excellent in emulsion stability (in particular, storage stability with aging at room temperature). Can. In the present disclosure, room temperature refers to “25 ⁇ 3 ° C.”.
- tea extract is known to have a deodorizing effect.
- the stability of the oil-in-water emulsion composition with aging at room temperature It turned out that the sex worsens.
- the present inventors repeatedly studied, among the tea extract, it contains a water-soluble tea extract containing 20% by mass or more of tea polyphenol in a specific amount, and further contains an oily component, enzyme-degraded lecithin, and sucrose fatty acid ester
- a water-soluble tea extract containing 20% by mass or more of tea polyphenol in a specific amount
- an oily component containing 20% by mass or more of tea polyphenol in a specific amount
- an oily component enzyme-degraded lecithin
- sucrose fatty acid ester sucrose fatty acid ester
- the oil-in-water type composition of the present disclosure is excellent in the stability of the oil-in-water type emulsion composition when stored in a refrigerator by using the above-mentioned configuration, and also as oil-in-water by astaxanthin compounded in high concentration.
- An increase in viscosity of the emulsion composition can be suppressed, and it is considered that the formulation suitability as an oil-in-water emulsion is obtained.
- refrigeration storage refers to storage at an ambient temperature of "more than 1 ° C. and 10 ° C. or less".
- cold storage and cold storage are synonymous.
- said estimation does not limit interpretation of the oil-in-water type composition of this indication, and demonstrates it as an example.
- the oil-in-water emulsion composition of the present disclosure contains astaxanthin.
- the oil-in-water emulsion composition of the present disclosure contains astaxanthin.
- astaxanthin and its derivatives are collectively referred to as “astaxanthin” unless otherwise noted. That is, the oil-in-water emulsion composition of the present disclosure contains, as astaxanthin, at least one selected from the group consisting of astaxanthin and its derivatives. Derivatives of astaxanthin include esters of astaxanthin and the like.
- Astaxanthin in addition to astaxanthin derived from natural products such as plants, algae, crustaceans and bacteria, synthetic products of astaxanthin obtained according to a conventional method can also be used. Astaxanthin can be extracted from cultures of red yeast Phaffia, green algae Haematococcus, marine bacteria, krill and the like. From the viewpoint of quality and productivity, astaxanthin is preferably an astaxanthin derived from an extract from Haematococcus alga (hereinafter referred to as "Hematococcus alga extract”) or an extract from krill, with Haematococcus alga Astaxanthin derived from the extract is particularly preferred.
- Hematococcus alga extract an extract from Haematococcus alga extract
- Haematococcus alga Astaxanthin derived from the extract is particularly preferred.
- astaxanthin is preferably dissolved in an oil component to be described later. That is, astaxanthin can be added to the oil-in-water emulsion composition of the present disclosure in the form of an astaxanthin-containing oil in which astaxanthin is contained in the oil component.
- Haematococcus alga Specific examples include Haematococcus pluvialis, Haematococcus lacustris, Haematococcus capensis, Haematococcus d'Obiensis, Encis (Haematococcus zimbabwiensis) etc. are mentioned. Among these, Haematococcus pluvialis is preferable as a Haematococcus alga.
- the Haematococcus alga extract is prepared by crushing the cell wall of the Haematococcus alga according to the method disclosed in, for example, JP-A-5-68585, if necessary, acetone, ether, chloroform, alcohol (ethanol, methanol, etc. And the like, or an extraction solvent such as carbon dioxide in a supercritical state, or the like.
- a commercial item may be used as a Haematococcus alga extract.
- Examples of commercial products of Haematococcus alga extract include Fujifilm Co., Ltd. ASTOTS (registered trademark) -S, ASTOTS (registered trademark) -5O, ASTOTS (registered trademark) -10O, etc., Fuji Chemical Industry Co., Ltd. Astearyl (registered trademark) oil 50F, Astarille (registered trademark) oil 5F, and the like, and BioAstin SCE7 of Toyo Enzyme Chemical Co., Ltd., and the like.
- the content of astaxanthin as a pure pigment in the Haematococcus alga extract is preferably 0.001% by mass to 50% by mass, and more preferably 0.01% by mass to 40% by mass from the viewpoint of handling at the time of production. It is mass%.
- the Haematococcus alga extract may contain astaxanthin or an ester thereof as a pure pigment, similarly to the pigment described in JP-A-2-49091.
- the content of astaxanthin in the oil-in-water emulsion composition of the present disclosure is 0.1% by mass to 20.0% by mass.
- the content of astaxanthin is preferably 0.2% by mass or more with respect to the total mass of the oil-in-water emulsion composition, from the viewpoint of sufficiently obtaining the expected effect by containing astaxanthin, for example.
- the content is more preferably 4% by mass or more, further preferably 1.0% by mass or more.
- the content of astaxanthin is, for example, preferably 10% by mass or less and 8% by mass or less based on the total mass of the oil-in-water emulsion composition from the viewpoint of ease of intake. More preferable.
- the oil-in-water emulsion composition of the present disclosure contains an oil component.
- the oil component in the oil-in-water emulsion composition of the present disclosure is a component having a solubility of less than 0.1% by mass (less than 1 g / L) in water at 25 ° C.
- the oily component can be suitably used as a compound used for the purpose of dissolving astaxanthin. Astaxanthin is not included in the oil component of the oil-in-water emulsion composition of the present disclosure.
- the oily component preferably contains at least one selected from the group consisting of medium-chain fatty acid triglycerides and animal and vegetable fats and oils from the viewpoint of affinity with astaxanthin and the Food Sanitation Law.
- medium-chain fatty acid triglycerides include medium-chain fatty acid triglycerides in which the fatty acid constituting the triglyceride has 8 to 10 carbon atoms.
- animal and vegetable fats and oils include soybean oil, rapeseed oil, cottonseed oil, sunflower oil, safflower oil, coconut oil, wheat germ oil, corn germ oil, corn oil, olive oil, rice bran oil, vegetable oil such as coconut oil, liver oil, fish oil And animal fats and oils such as soy sauce.
- medium-chain fatty acid triglyceride is preferable, and as an oil component contained in the oil-in-water emulsion composition of the present disclosure, only medium-chain fatty acid triglyceride is more preferable.
- astaxanthin may be contained in an oil-in-water emulsion composition of the present disclosure as an astaxanthin-containing oil in which astaxanthin is contained in an oil component, and astaxanthin is derived from antioxidant B described later It is also good.
- the astaxanthin-containing oil preferably contains medium-chain fatty acid triglyceride as an oil component.
- the oil component may be only one type or may be a combination of two or more types.
- the total content of the oil component is preferably in the range of 15% by mass to 50% by mass, and more preferably in the range of 20% by mass to 50% by mass, with respect to the total mass of the oil-in-water emulsion composition. Is more preferred.
- the oil-in-water emulsion composition of the present disclosure contains a water-soluble tea extract having a content of more than 0% by mass and 2.0% by mass or less based on the total mass of the oil-in-water emulsion composition.
- the water-soluble tea extract used for the oil-in-water emulsion composition of the present disclosure contains 20% by mass or more of tea polyphenol based on the total mass of the water-soluble tea extract.
- the water-soluble tea extract used for the oil-in-water emulsion composition of the present disclosure is not particularly limited as long as its solubility in water at 25 ° C. is 20% by mass or more (200 g / L or more).
- the water-soluble tea extract is extracted from one or two or more kinds of tea leaves selected from green tea, oolong tea, and black tea, and tea polyphenols (catechins) relative to the total mass of the water-soluble tea extract 20% by mass or more.
- the solvent used for extraction (also referred to as “extraction solvent”) is not particularly limited, and examples thereof include hot water, methanol, ethanol, isopropanol, ethyl acetate and the like.
- extraction solvent is carried out using a mixture of one or more of these extraction solvents to obtain an extract containing a water-soluble tea extract.
- the extract can be used as it is, preferably in the form of a powder from which water has been removed by spray drying, freeze drying, etc., which can easily be used, and those formulated with dextrin, glycerin or the like can also be used. .
- the water-soluble tea extract functions as an antioxidant.
- the water-soluble tea extract according to the present disclosure is also referred to as "antioxidant A".
- the lower limit of the content of the antioxidant A is preferably 0.1% by mass or more, more preferably 0.3% by mass or more based on the total mass of the oil-in-water emulsion composition .
- the upper limit of the content of the antioxidant A is not particularly limited from the viewpoint of reducing the viscosity of the oil-in-water emulsion composition by astaxanthin and making the production suitability favorable, but from the viewpoint of emulsion stability It is not more than mass%, preferably not more than 15.0 mass%, more preferably not more than 10.0 mass%, still more preferably not more than 8.0 mass%, still more preferably 5.0 mass% It is below.
- antioxidant A commercially available products can also be used, and Sunfood (registered trademark) 100, CD, aqueous, powder (30%) (trade name, manufactured by Mitsubishi Chemical Foods Co., Ltd.), Sanphenone (registered trademark) Trademarks 30S-OP, EGCG-OP, BG-3, 90S, 90MB-OP (all trade names, manufactured by Taiyo Kagaku Co., Ltd.), Polyphenon (registered trademark) G, 70S, PF (all trade names, Mitsui Norin and Forest Co., Ltd., N Theafran (registered trade ticket) 30A, 90S (all trade names, manufactured by Itoen Co., Ltd.), San-Oulong (registered trademark, trade name, manufactured by Suntory Ltd.), and the like.
- Antioxidant A is a catechins having a basic structure of flavan-3-ol, that is, epicatechin, epigallocatechin, epicatechin gallate, as a tea polyphenol from the viewpoint of achieving both odor reduction and emulsion stability. It is preferable to include one or more selected from the group consisting of gallocatechin gallate, catechin, gallocatechin, catechin gallate, and gallocatechin gallate. From the viewpoint of reducing the odor, the content of the tea polyphenol with respect to the total mass of the antioxidant A is preferably 40% by mass or more, more preferably 50% by mass or more, still more preferably 70% by mass or more, and 80% by mass or more More preferable.
- the tea polyphenol contains 10% by mass or more of at least one or more of epigallocatechin gallate or epigallocatechin preferable.
- an upper limit is 50 mass% or less from a viewpoint of enabling sufficient odor reduction, suppressing the bitterness peculiar to tea.
- At least one of the water phase and the oil phase may contain the antioxidant A, but from the viewpoint of suppressing the odor derived from the raw material of astaxanthin more effectively, Antioxidant A is preferably contained in the aqueous phase.
- the antioxidant A when the antioxidant A is contained in the water phase, the odor diffuses to the water phase which is the continuous phase because it is present at the interface of the oil phase in the oil-in-water composition I think that is because it is holding down things.
- the oil-in-water emulsion composition of the present disclosure contains at least one antioxidant (hereinafter also referred to as "antioxidant B") different from the water-soluble tea extract (antioxidant A) described above. It is also good.
- antioxidant B is not particularly limited.
- antioxidant B examples include at least one compound selected from the group consisting of ascorbic acid, ascorbic acid derivatives, and salts thereof, vitamin E such as tocopherol and derivatives thereof, vitamin A, retinoic acid, retinol, Retinol acetate, retinol palmitate, retinyl acetate, retinyl palmitate, tocopheryl retinoic acid, vitamin C and its derivatives, kinetin, retinoin, sesamin, ⁇ -lipoic acid, coenzyme Q10, flavonoids, erythorbic acid, propyl gallate, BHT (di-n-butylhydroxytoluene), BHA (butylhydroxy anisole), tretinoin, polyphenol, SOD (superoxide dismutase), phytic acid, kanoki extract, soy extract, AGEZEKI , And the like rosemary extract.
- vitamin E such as tocopherol and derivatives thereof
- vitamin A retinoi
- antioxidant B is at least one compound selected from the group consisting of ascorbic acid, ascorbic acid derivatives, and salts thereof, vitamin E and its derivatives such as tocopherol, vitamin A, retinoic acid, retinol, and , Retinol acetate, more preferably, at least one compound selected from the group consisting of ascorbic acid, ascorbic acid derivatives, and salts thereof, and vitamin E such as tocopherol and derivatives thereof, still more preferably And vitamin E such as tocopherol and derivatives thereof.
- the content of the antioxidant B in the oil-in-water emulsion composition of the present disclosure can be appropriately set according to the type of the antioxidant B, in consideration of maintenance of the emulsion stability of astaxanthin and the like.
- the content of the antioxidant B is preferably 0.1 times to 100 times the mass of astaxanthin, more preferably 0.1 times to 10 times the mass, and 0 It is more preferable that the amount is 1 to 5 times the amount.
- the ascorbic acid and the salt thereof Specifically, ascorbic acid, sodium ascorbate, potassium ascorbate, calcium ascorbate and the like can be mentioned.
- ascorbic acid derivatives and salts thereof ascorbic acid phosphate and salts thereof, ascorbic acid sulfate and salts thereof, palmitate acid ascorbyl phosphate and salts thereof and the like can be mentioned.
- a preferred embodiment of the antioxidant B contained in the oil-in-water emulsion composition of the present disclosure is at least one compound selected from the group consisting of ascorbic acid, ascorbic acid derivatives, and salts thereof, and / or , Vitamin E such as tocopherol and its derivatives.
- Vitamin E such as tocopherol and its derivatives.
- the antioxidant B in the oil-in-water emulsion composition of the present disclosure at least one compound selected from the group consisting of ascorbic acid, ascorbic acid derivatives, and salts thereof, and / or vitamin E such as tocopherol and the like
- the total content is preferably 0.5% by mass to 6% by mass with respect to the total mass of the oil-in-water emulsion composition of the present disclosure, and the low temperature of these compounds is low. From the viewpoint of suppressing precipitation with time, 0.5% by mass to 4% by mass is more preferable, and 0.5% by mass to 3% by mass is more preferable.
- the compounds of the group consisting of ascorbic acid, ascorbic acid derivatives, and salts thereof, and / or vitamin E and derivatives thereof such as tocopherol may be only one kind or a combination of two or more kinds.
- the oil-in-water emulsion composition of the present disclosure preferably contains antioxidant B in the oil phase composition.
- the oil-in-water emulsion composition of the present disclosure may use a water-soluble antioxidant other than the water-soluble tea extract (antioxidant A) as long as the effect is not impaired. It is preferable from the viewpoint of emulsion stability that no water-soluble antioxidant other than A is used.
- the content of the water-soluble tea extract and the antioxidant B is preferably 0.6% by mass to 11% by mass with respect to the total mass of the oil-in-water emulsion composition, It is more preferable that it is 1.0 mass% or more and 8.0 mass% or less.
- Enzymatic degradation lecithin The oil-in-water emulsion composition of the present disclosure comprises enzyme-degraded lecithin.
- Lecithin is a generic name for a mixture containing various phospholipids, such as phosphatidyl choline (PC).
- Enzyme-degraded lecithin also called lysolecithin is a composition containing lysophosphatidylcholine in which one fatty acid possessed by a phosphatidylcholine molecule is lost by an enzyme such as phospholipase.
- the enzyme-degraded lecithin is a so-called hydrogenated enzyme-degraded lecithin in which the oxidation stability is improved by performing a hydrogenation treatment to convert the bound fatty acid into a saturated fatty acid.
- the concentration of lysophosphatidylcholine contained in the enzyme-degraded lecithin is preferably 18% by mass to 75% by mass, and is 18% by mass to 65% by mass. It is preferable that it is 18 mass% or more and 30 mass% or less.
- the content of the enzyme-degraded lecithin in the oil-in-water emulsion composition of the present disclosure is preferably in the range of 0.00001% by mass to 7% by mass with respect to the total mass of the oil-in-water emulsion composition. More preferably, it is in the range of 00001% by mass to 5% by mass. From the viewpoint of securing the emulsion stability while suppressing the taste derived from the enzyme-degraded lecithin, the content of the enzyme-degraded lecithin is from 0.00001% by mass to 3.0% by mass with respect to the total amount of the oil-in-water emulsion composition. It is preferable that it is% or less.
- enzyme-degraded lecithin commercially available enzyme-degraded lecithin can be used.
- the oil-in-water emulsion composition of the present disclosure comprises sucrose fatty acid ester.
- the oil-in-water emulsion composition of the present disclosure contains sucrose fatty acid ester, whereby the absorbability of astaxanthin in the body is improved and the emulsion stability with time is improved.
- the oil-in-water emulsion composition of the present disclosure may contain sucrose fatty acid ester singly or in combination of two or more.
- the HLB value of the sucrose fatty acid ester is 10 or more, preferably 12 or more, and more preferably 14 or more from the viewpoint of the absorbability of astaxanthin in the body.
- the HLB value of sucrose fatty acid ester is preferably 19 or less from the viewpoint of exhibiting amphiphilicity.
- the carbon number of the fatty acid constituting the sucrose fatty acid ester is, for example, preferably 8 or more, more preferably 10 to 18, from the viewpoint of exhibiting amphiphilic property.
- Specific examples of sucrose fatty acid esters include sucrose laurate, sucrose myristate, sucrose palmitate, sucrose stearate, sucrose oleate and the like.
- the oil-in-water emulsion composition of the present disclosure has a ratio of mono-substituted body (also referred to as mono-ester body) to the total mass of sucrose fatty acid ester from the viewpoint of enhancing the emulsion stability at low temperature preferable.
- the proportion of monoesters may be 100% by mass (that is, all sucrose fatty acid esters are monoesters).
- the oil-in-water emulsion composition of the present disclosure more preferably contains sucrose stearic acid ester as sucrose fatty acid ester.
- the content rate of monoester body in sucrose stearate can be measured by the following method.
- Sucrose stearic acid ester is added to tetrahydrofuran in an amount of 1 mg / mL and dissolved to obtain a sample solution.
- ⁇ Method for calculating content rate of monoester body The ratio of the peak area at a retention time of 17 minutes to 22 minutes to the total peak area at a retention time of 15 minutes to 30 minutes in high performance liquid chromatography is calculated, and this is taken as the content of monoester body.
- the sucrose fatty acid ester containing 75% by mass to 100% by mass of the monoester body can be selected and used as a commercially available product as described below in which the content of the monoester body is 75% by mass or more.
- a mixture in which the content of the monoester body is 75% by mass or more by mixing a plurality of the following commercial products may be used, and the purification of the commercial article having a content of monoester body of less than 75% by mass
- a purified product in which the content of monoester body is increased to 75% by mass or more may be used.
- Ryoto registered trademark
- Sugar ester S-070, S-170, S-270, S-370, S-370F, S-570, S-770, S-970, S-170, S-1170, S-1170F, S-1570, S-1670 all trade names, manufactured by Mitsubishi Chemical Foods Co., Ltd.
- DK ester registered trademark
- SS DK ester
- F160, F140, F110, F90, F70, F50, F-20W, F-10, FA-10E Cosmetics, S-10, S-50, S-70, S-110, S-160, S-190 (trade names, manufactured by Daiichi Kogyo Seiyaku Co., Ltd.), etc.
- Cosmetics, S-10, S-50, S-70, S-110, S-160, S-190 (trade names, manufactured by Daiichi Kogyo Seiyaku Co., Ltd.), etc. Can be mentioned.
- Ryoto sugar ester S-1170, S-1170F, S-1570, S-1670, DK ester SS, F160, F140, F110, cosmetic like S-110, S-160, S-19 and the like are preferable. It is most preferable to consist only of DK ester SS because the ratio of the content of monoester body is high.
- the content of sucrose fatty acid ester is, for example, preferably 0.1% by mass or more based on the total mass of the oil-in-water emulsion composition, from the viewpoint of absorbability of astaxanthin in the body. It is more preferable that it is mass% or more, and it is still more preferable that it is 0.5 mass% or less. Moreover, it is preferable that the content rate of sucrose fatty acid ester is 10 mass% or less with respect to the total mass of an oil-in-water type emulsion composition, for example from an emulsion stability viewpoint.
- the oil-in-water emulsion composition of the present disclosure more preferably comprises a polyglycerin fatty acid ester.
- the polyglycerin fatty acid ester is preferably a polyglycerin fatty acid ester having at least one of a saturated fatty acid structure having 10 or more carbon atoms, a branched fatty acid structure and an unsaturated fatty acid structure.
- polyglycerin fatty acid ester in the present disclosure polyglycerin having an average polymerization degree of preferably 6 to 20, more preferably 8 to 16 and still more preferably 8 to 10, saturated fatty acid having 10 to 22 carbon atoms, and 8 carbon atoms
- examples thereof include esters of fatty acids selected from unsaturated fatty acids of ⁇ 22 and branched saturated fatty acids having 8 to 22 carbon atoms.
- the C10-22 saturated fatty acid includes a C10-22 linear saturated fatty acid and a C10-22 branched unsaturated fatty acid, and the C8-22 unsaturated fatty acid And C 8-22 linear unsaturated fatty acids and C 8-22 branched unsaturated fatty acids.
- the polyglycerin fatty acid ester is preferably an ester having a fatty acid structure selected from a saturated fatty acid structure having 10 to 22 carbon atoms, an unsaturated fatty acid structure having 8 to 22 carbon atoms, and a branched saturated fatty acid structure having 8 to 22 carbon atoms.
- esters of a fatty acid having at least one of a saturated fatty acid structure of several 10 to 22 carbon atoms, a branched fatty acid structure of 16 to 22 carbon atoms and an unsaturated fatty acid structure of 16 to 22 carbon atoms is more preferable, and a saturated fatty acid of 10 to 20 carbon atoms
- esters of fatty acids having at least one of the structures, branched fatty acid structures having 16 to 18 carbon atoms and unsaturated fatty acid structures having 16 to 18 carbon atoms are particularly preferred.
- the fatty acid selected from saturated fatty acids having 10 to 22 carbon atoms include lauric acid, myristic acid, palmitic acid and stearic acid.
- examples of the fatty acid selected from unsaturated fatty acids having 8 to 22 carbon atoms and branched saturated fatty acids having 8 to 22 carbon atoms include oleic acid, linoleic acid and isostearic acid.
- the polyglycerin fatty acid ester may be a monoester or a diester, but is preferably a monoester.
- polyglycerin fatty acid ester has a surface activity ability.
- compounds having an HLB of 5 or more are preferable, compounds of 8 or more are more preferable, and compounds of 10 or more are even more preferable.
- the upper limit of the HLB of the polyglycerin fatty acid ester is not particularly limited, but is preferably 20 or less, more preferably 18 or less.
- Preferred specific examples of the polyglycerin fatty acid ester include decaglycerin laurate, decaglycerin myristate, decaglycerin palmitate, decaglycerin stearate, hexaglycerin monooleate, decaglycerin monooleate, decaglycerin Glycerin linoleic acid ester, decaglycerin isostearic acid ester, hexaglycerin isostearic acid ester, decaglycerin mono isostearic acid ester, etc.
- decaglycerin laurate decaglycerin myristic ester, decaglycerin palmitic acid ester, decaglycerin Consisting of glycerin stearic acid ester, polyglyceryl isostearate and polyglyceryl oleate It is preferably at least one more selectively.
- the polyglycerin fatty acid ester may be a commercially available product, and as a commercially available product, for example, NIKKOL (registered trademark) Decaglyn 1-ISV, NIKKOL Decaglyn 1-OV, NIKKOL Decaglyn 1-LN, NIKKOL Decaglyn, manufactured by Nikko Chemicals Co., Ltd. 1-PVEX, NIKKOL Decaglyn 1-SVEX, NIKKOL Decaglyn 1-L, NIKKOL Decaglyn 1-M, Ryoto polyglycol ester O-15D manufactured by Mitsubishi Chemical Foods Co., Ltd. O-15D, manufactured by Sun Chemical Co., Ltd. Soft Q-17S and Poem J-0381V manufactured by Riken Vitamin Co., Ltd. can be mentioned.
- NIKKOL registered trademark
- decaglycerin monolaurate decaglycerin stearic acid ester, decaglycerin monomyristic acid ester, decaglyceryl palmitate, decaglycerin monooleate, decaglycerin monoisostearic acid ester, etc. .
- the oil-in-water emulsion composition of the present disclosure may contain only one type of polyglycerin fatty acid ester, or may contain two or more types.
- the content of the polyglycerin fatty acid ester in the oil-in-water emulsion composition of the present disclosure is preferably 2% by mass to 22% by mass, and more preferably 5% by mass to 22% by mass with respect to the total mass of the oil-in-water emulsion composition. More preferably, it is mass%.
- the content of the polyglycerin fatty acid ester relative to the sucrose fatty acid ester is preferably 2-fold to 13-fold.
- the oil-in-water emulsion of the present disclosure contains water.
- the water is not particularly limited, and natural water, purified water, distilled water, ion exchanged water, pure water, ultrapure water (Milli-Q water etc.), etc. can be used.
- the Milli-Q water is ultrapure water obtained by Milli-Q water production apparatus manufactured by Merck Co. Merck.
- the oil-in-water emulsion composition of the present disclosure preferably contains an emulsifier.
- an emulsifier in the oil-in-water emulsion composition of the present disclosure it is preferable to contain only one or more selected from the group consisting of enzyme-degraded lecithin, sucrose fatty acid ester and polyglycerin fatty acid ester described above, Other emulsifiers may be contained as long as the expected effects of the oil-in-water emulsion composition of the present disclosure are not impaired.
- lecithins other than enzyme-degraded lecithin, saponins, sterols, etc.
- containing only one or more selected from the group consisting of enzyme-degraded lecithin, sucrose fatty acid ester and polyglycerin fatty acid ester as an emulsifier means enzyme-degraded lecithin, sucrose fatty acid ester and polyglycerin fatty acid
- the content of the emulsifier other than the ester is 1% by mass or less with respect to the total mass of the oil-in-water emulsion composition.
- the content of the other emulsifier is preferably 0.001% by mass or more and 1% by mass or less, more preferably 0.01% by mass or more and 1% by mass or less, and 0.01% by mass or more and 0.5% or more. It is further preferable that the content is at most mass%.
- sucrose fatty acid ester and polyglycerin fatty acid ester When only one or more selected from the group consisting essentially of enzyme-degraded lecithin, sucrose fatty acid ester and polyglycerin fatty acid ester is contained as an emulsifier in the oil-in-water emulsion composition of the present disclosure,
- the ratio of the sugar fatty acid ester: polyglycerin fatty acid ester is preferably 0.00001: 15: 1 to 7: 1: 15 in weight ratio.
- the oil-in-water emulsion composition of the embodiments of the present disclosure preferably contains a polyhydric alcohol.
- the polyhydric alcohol is preferably at least one selected from the group consisting of glycerin, sorbitol and reduced starch, and it is more preferably at least one selected from glycerin or reduced starch preferable.
- Glycerin is preferably used because it reduces the average particle size of the astaxanthin-containing emulsified particles and facilitates stable retention over a long period with the particle size remaining small.
- the content of glycerin is preferably in the range of 20% by mass to 60% by mass with respect to the total mass of the oil-in-water emulsion composition, and is preferably 20% by mass to 50%.
- the range of mass% or less is more preferable, and the range of 30% by mass or more and 60% by mass or less is more preferable.
- the content of glycerin is preferably 1 to 100 times the mass of astaxanthin, and more preferably 2 to 50 times the mass. Preferably, it is more preferably 2 times or more and 10 times or less.
- the reduced starch syrup is a kind of sugar alcohol and is synthesized by reducing (ie, hydrogenating) the starch syrup.
- the reduced starch syrup can be adjusted in viscosity by changing the composition of the starch syrup (i.e., saccharides) that is the raw material, and is classified into highly saccharified reduced starch syrup and reduced saccharified reduced starch syrup.
- the reduced saccharified reduced starch syrup is preferably used because the average particle system of the emulsified particles containing astaxanthin can be reduced and the particle diameter can easily be stably maintained over a long period with the particle diameter kept small.
- a reduced starch syrup is particularly preferably a starch syrup in which an oligotose (linear oligosaccharide) is reduced.
- the origin of the oligotose is not particularly limited, it is preferably a linear oligosaccharide having maltotriose (G3) as a main component, preferably a linear oligosaccharide having maltotriose as a main component, and It is more preferable that the content of sugar and high molecular weight dextrin be low.
- the reduced starch syrup may be a commercially available product.
- Examples of commercially available products of reduced starch syrup include oligotos (Sanwa Starch Co., Ltd.), oligotos (trade name, product food science (trade)), SE 30 (trade name, product food science (trade)), SE 100 (Trade name, product food sciences corporation) oligotos H-70 (Mitsubishi Chemical Foods Ltd.), halodex (trade name, Hayashibara Co., Ltd.), Tetrap, Tetrap-H (trade name, Hayashibara Co., Ltd.) , Pentrap (trade name, Hayashibara Co., Ltd.), coupling sugar (trade name, Hayashibara Co., Ltd.), coupling sugar S (trade name, Hayashibara Co., Ltd.), and the like.
- the reduced starch syrup may be either solid (powdery) or liquid including a solvent (for example, water and the like), but is preferably liquid from the viewpoint of productivity.
- a solvent for example, water and the like
- Commercially available liquid reduced starch syrup often contains 20% by mass or more and 40% by mass or less of water, but may contain water outside this range as long as a desired effect is obtained.
- the content of the reduced starch syrup in the oil-in-water emulsion composition of the present disclosure is preferably in the range of 30% by mass to 70% by mass with respect to the total amount of the oil-in-water emulsion composition, and is 35% by mass to 70%.
- the range of mass% or less is more preferable, and the range of 40% by mass to 70% by mass is more preferable.
- the content rate of the reduced starch in the oil-in-water emulsion composition in the present disclosure means a mass based content rate of the solid content of the reduced starch contained in the oil-in-water emulsion composition.
- the content of the reduced starch syrup is preferably 1 to 100 times the mass of astaxanthin, and is 2 to 50 times the mass The amount is more preferably 2 times or more and 10 times or less.
- polyhydric alcohols polyhydric alcohols other than glycerin and reduced starch syrup are preferably not used when the oil-in-water emulsion composition of the present embodiment is used in food.
- the oil-in-water emulsion composition of the present disclosure may contain one or more optional other components as necessary, in addition to the components described above.
- Other components include, for example, physiologically active components other than astaxanthin such as nutritional components, active ingredients, and pharmacological components, pigments (not including astaxanthin), antioxidants, liquid sugars such as blisters, and the like.
- physiologically active components other than astaxanthin such as nutritional components, active ingredients, and pharmacological components, pigments (not including astaxanthin), antioxidants, liquid sugars such as blisters, and the like.
- pigments not including astaxanthin
- antioxidants such as antioxidants, liquid sugars such as blisters, and the like.
- Such other components are not particularly limited as long as they can be used for food and drink, medicines.
- the oil-in-water emulsion composition of the present disclosure is prepared by preparing a mixed solution of an oil phase composition containing astaxanthin and an oily component, and an aqueous phase composition containing water, sucrose fatty acid ester and enzyme-degraded lecithin. It is preferable to manufacture by the manufacturing method including emulsifying the mixed liquid by a conventional method.
- the water-soluble tea extract (antioxidant A) may be contained in either the oil phase composition or the water phase composition, but from the viewpoint of effectively suppressing the odor, the water phase composition preferably contains .
- the oil-in-water emulsion composition of the present disclosure contains the antioxidant A, it can reduce the increase in viscosity of the oil-in-water emulsion composition while containing a high concentration of astaxanthin, and therefore, is suitable for manufacturing Excellent.
- the liquid mixture to be subjected to emulsification may be prepared by combining the prepared oil phase composition and water phase composition after separately preparing the oil phase composition and the water phase composition separately, or The components included in the composition and the aqueous phase composition may be prepared by mixing together or sequentially mixing them.
- the oil phase composition may contain other optional components as well as astaxanthin and an oily component.
- an oily component From the viewpoint of enhancing the stability of astaxanthin, at least one compound selected from the group consisting of ascorbic acid, ascorbic acid derivatives, and salts thereof as an antioxidant different from antioxidant A (antioxidant B), And at least one compound selected from the group consisting of vitamin E such as tocopherol and derivatives thereof, and salts thereof.
- the aqueous phase composition contains water, enzyme-degraded lecithin and sucrose fatty acid ester, and preferably contains antioxidant A.
- the aqueous phase composition is preferably prepared by preparing a solution in which an enzyme-degraded lecithin and sucrose fatty acid ester are dissolved in a polyhydric alcohol, and then adding the antioxidant A and water to the solution.
- an oil-in-water emulsion composition for example, a) water, an enzyme-degraded lecithin, a sucrose fatty acid ester, and an antioxidant A are mixed and dissolved to obtain an aqueous phase composition. B) Astaxanthin and an oily component are mixed and dissolved to obtain an oil phase composition, and c) the aqueous phase composition and the oil phase composition are mixed under stirring to form a mixed liquid, Emulsify and disperse the resulting mixed solution.
- emulsification dispersion for example, after emulsification using a conventional emulsification device utilizing shearing action such as stirrer, impeller stirring, homomixer, or continuous flow shearing device, a method such as passing through a high pressure homogenizer It is preferable to use two or more emulsifying devices in combination. When a high pressure homogenizer is used, the emulsified particles can be made more uniform in particle size. Emulsifying and dispersing may be performed multiple times for the purpose of further homogenizing the particle size.
- the high-pressure homogenizer includes a chamber-type high-pressure homogenizer having a chamber to which a flow path of a processing solution is fixed, and a homogenization valve-type high-pressure homogenizer having a homogenization valve.
- the homogeneous valve type high-pressure homogenizer can easily adjust the width of the flow path of the treatment liquid, so that the pressure and flow rate at the time of operation can be arbitrarily set, and the operation range is wide. It can be preferably used in the production of an oil-type emulsion composition. Although the degree of freedom in operation is low, it is easy to create a mechanism for increasing the pressure, so a chamber type high pressure homogenizer can also be suitably used for applications requiring ultra high pressure.
- Examples of the chamber type high pressure homogenizer include Microfluidizer (manufactured by Microfluidics Co., Ltd.), Nanomizer (manufactured by Yoshida Kikai Kogyo Co., Ltd.), Ultimizer (manufactured by Sugino Machine Co., Ltd.), and the like.
- a homogeneous valve type high pressure homogenizer As a homogeneous valve type high pressure homogenizer, a Gorin type homogenizer (manufactured by APV), a Lanier type homogenizer (manufactured by Lanier), a high pressure homogenizer (manufactured by Niro Soavi), a homogenizer (manufactured by Sanwa Kikai Co., Ltd.), a high pressure homogenizer (manufactured by Sanwa Kikai Co., Ltd.) Izumi Food Machinery Co., Ltd. product, an ultra-high pressure homogenizer (manufactured by Squid Co., Ltd.), etc. may be mentioned.
- the pressure of the high pressure homogenizer is preferably 50 MPa or more, more preferably 50 MPa or more and 250 MPa or less, and still more preferably 100 MPa or more and 250 MPa or less.
- the obtained oil-in-water emulsion composition is preferably cooled through any cooler within 30 seconds immediately after passage through the chamber, preferably within 3 seconds, from the viewpoint of maintaining the particle diameter of the emulsified particles.
- oil-in-water emulsion composition when the obtained oil-in-water emulsion composition is applied as an oil-in-water emulsion composition for soft capsule preparation, it is preferable to degas from the viewpoint of preventing expansion and the like of the soft capsule.
- the odor derived from the raw material of astaxanthin is derived from a plurality of substances, and one of the causative substances thereof is 2,4-heptadienal. Therefore, from the viewpoint of reducing the odor, the content (A) of 2,4-heptadienal is preferably 1000 ppb or less, more preferably 800 ppb or less, still more preferably 500 ppb or less based on the total mass of the oil-in-water emulsion composition. .
- the smell of algae (a raw odor or smell of fish like algae coming out of the nose after containing in the mouth) 200 ppb or less is preferable, 100 ppb or less is more preferable, and 80 ppb or less is more preferable for the content (B) of 2,4-heptadienal converted to 100 parts by mass of a 1% by mass astaxanthin-containing oil-in-water emulsion to be calculated.
- (B) (A) / Astaxanthin content in oil-in-water emulsion composition ...
- a method of preparing an oil-in-water emulsified composition of the present disclosure using purified astaxanthin after purifying the raw material of astaxanthin itself by a known deodorizing method and (2) A method of purifying the oil-in-water emulsion composition of the present disclosure and then purifying it by a known deodorizing method, Or the like may be used.
- known deodorizing methods include supercritical extraction methods, separation and purification methods using porous adsorbents such as activated carbon and silica gel, masking methods, ozone oxidation methods, catalytic combustion methods and the like.
- the method of measuring the content of 2,4-heptadienal in the oil-in-water emulsion composition of the present disclosure is not particularly limited as long as the content of 2,4-heptadienal in the oil-in-water emulsion composition can be measured.
- Graph analysis is preferred, and gas chromatograph analysis or liquid chromatograph analysis is more preferred.
- head space gas chromatography mass spectrometry, purge and trap gas chromatography mass spectrometry Etc. are mentioned as a more preferable method.
- 2,4-heptadienal includes structural isomers.
- the viscosity of the oil-in-water emulsion composition of the present disclosure is not particularly limited, but is preferably 600 mPa ⁇ s or less, and more preferably 500 mPa ⁇ s or less, from the viewpoint of production suitability for emulsion dispersion and the like. Although a lower limit in particular is not restrict
- the viscosity of the oil-in-water emulsion composition is not particularly limited as long as it is measured according to JIS Z8803 (2011), and a value measured at 25 ° C. is used.
- the average particle size (volume-average particle size) of the oil-in-water emulsion composition of the present disclosure is not particularly limited, but is preferably 5 nm to 200 nm, and good transparency and stability of the oil-in-water emulsion composition From the viewpoint, 10 nm to 150 nm is more preferable, and 10 nm to 120 nm is more preferable.
- the average particle size (volume-average particle size) of the oil-in-water emulsion composition can be measured with a commercially available particle size distribution analyzer or the like.
- a method of particle size distribution measurement optical microscopy, confocal laser microscopy, electron microscopy, atomic force microscopy, static light scattering, laser diffraction, dynamic light scattering, centrifugal sedimentation, electric pulse measurement
- a method, a chromatography method, an ultrasonic attenuation method etc. are mentioned, it is not limited to these.
- the particle size measurement is preferably performed by dynamic light scattering.
- Nanotrac UPA (trade name, Nikkiso Co., Ltd.), dynamic light scattering particle size distribution analyzer LB-550 (trade name, Horiba, Ltd.) as a commercially available measurement apparatus using a dynamic light scattering method And concentrated particle size analyzer FPAR-1000 (trade name, Otsuka Electronics Co., Ltd.), etc., but if the particle size can be measured based on the principle of the dynamic light scattering method, a measuring apparatus Is not limited to these.
- the average particle size of the oil-in-water emulsion composition is, for example, a sample in the apparatus of the oil-in-water emulsion composition diluted 100 times using Otsuka Electronics Co., Ltd., concentrated particle size analyzer FPAR 1000 (trade name). It can be put in a cell, and the value measured at 25 ° C. can be adopted to measure the 50% cumulative particle diameter.
- the oil-in-water emulsion composition of the present disclosure can be made into a powdered form by drying.
- the drying method at the time of pulverizing the oil-in-water emulsion composition is not particularly limited, and a conventional method such as spray drying, kneading granulation, freeze drying can be used.
- the powdered oil-in-water emulsion composition can be used as an oil-in-water emulsion composition by suspending it in a solvent containing water.
- the medium of the aqueous phase i.e., water
- the medium of the aqueous phase may be removed as much as possible when improving the flowability in powder form and the dispersibility in suspension.
- the removal of the aqueous phase medium may be carried out by a heating and drying means such as spray drying by spray drying.
- an oil-in-water emulsion composition substances known in the art necessary for pulverization, such as excipients, binders, disintegrants, lubricants, sweeteners, preservatives, coatings, stabilizers, etc.
- the composition may further contain additives such as a plasticizer, a fluidizer, a thickener, a solubilizer, a thickener, a buffer, a fragrance, a colorant, an emulsifier and the like.
- the content of the substance necessary for pulverization is not particularly limited, and can be set as appropriate.
- polymer substances such as, for example, carboxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, polyvinyl alcohol, polyvinylpyrrolidone and the like; gum arabic, tragacanth gum And natural polymers such as gelatin; additives such as powdered lactose, casein, microcrystalline cellulose, starch, flour, dextrin, boron dioxide and the like can be added.
- the oil-in-water emulsion composition of the present disclosure can be applied to various uses such as food or beverage (functional food or beverage, health food or beverage, etc.), medicine, quasi-drug, cosmetics etc. Since the odor derived from the raw material of astaxanthin can be reduced while containing astaxanthin at a high concentration, the oil-in-water emulsion composition of the present disclosure is preferably used for food or beverage, and particularly preferably used for beverages. Can.
- a food, medicine, quasi-drug or cosmetic dosage form to which the oil-in-water emulsion composition of the present disclosure is applied for example, liquid preparation and solid preparation obtained by drying it (powder, granules Etc.).
- the oil-in-water emulsion composition of the present disclosure can be applied to a liquid preparation and a solid preparation obtained by drying it, such as hard capsules, soft capsules, tablets and the like.
- a liquid preparation such as hard capsules, soft capsules, tablets and the like.
- excipients, disintegrants, binders, lubricants, surfactants, water-soluble polymers, sweeteners, flavoring agents, acidulants, etc. are further added according to the dosage form, and It can be manufactured according to
- the solid preparation formed by applying the oil-in-water emulsion composition of the present disclosure may be coated or sugar-coated by a known method.
- Soft capsule formulation One of the preferred application forms of the oil-in-water emulsion composition of the present disclosure is a soft capsule formulation comprising the oil-in-water emulsion composition of the present disclosure. That is, the soft capsule formulation of the present disclosure can be obtained by encapsulating the contents containing the oil-in-water emulsion composition of the present disclosure in a soft capsule coating. The contents of the soft capsule formulation of the present disclosure can include 0.0001% by mass to 95% by mass of the oil-in-water emulsion composition of the present disclosure with respect to the total amount of the soft capsule formulation.
- a substrate for forming a soft capsule film (hereinafter, also simply referred to as a film)
- a substrate mainly comprising agar, gelatin, gellan gum, transparency of the film, etc.
- a soft capsule film is prepared from a gelatin film liquid containing gelatin, a plasticizer, and water, when gelatin is used as a substrate for the film.
- gelatin to be used include gelatin, acidic gelatin, alkaline gelatin, peptidic gelatin, low molecular gelatin, gelatin derivatives and the like.
- the soft capsule film may contain a plasticizer, and as the plasticizer, glycerin; glycols such as propylene glycol and polyethylene glycol; saccharides such as corn syrup, sucrose, fructose, sorbitol and mannitol; crystalline cellulose, Examples thereof include starches, water-insoluble celluloses such as low substituted hydroxypropyl cellulose and ethyl cellulose. These plasticizers may be used alone or in any combination of two or more. As a plasticizer, glycerin is preferable.
- the soft capsule preparation may be appropriately blended with additives generally used in the field of food as long as the effects expected of the soft capsule preparation of the present disclosure are not impaired.
- additives include coloring agents such as coloring matter or pigment, preservatives, flavors, fruit juices, various vitamins, animal and plant extracts, amino acids, minerals, coloring agents, thickeners, pH adjusters, preservatives, disintegrations
- the components such as agents, surfactants, flavoring agents, flavoring agents, sweeteners, organic acids and the like can be mentioned, and these components can be appropriately selected and blended as needed.
- a method for producing a soft capsule preparation for example, (i) preparing the contents of the capsule and the composition for forming a film (hereinafter referred to as a composition preparation step), (ii) the obtained composition for forming a film The contents are enclosed, molded and dried to obtain an intermediate preparation (hereinafter referred to as a molding step), and (iii) drying the obtained intermediate preparation (hereinafter referred to as a drying step). And the method of producing more suitably.
- composition preparation step a content containing the oil-in-water emulsion composition of the present disclosure and a composition for film formation are respectively prepared.
- the method for preparing the oil-in-water emulsion composition of the present disclosure is as described above.
- the composition for film formation may be prepared as a solution in which a predetermined component contained in the composition is dissolved.
- the contents containing the oil-in-water emulsion composition of the present disclosure are enclosed in a film formed using the film-forming composition, molded and dried to obtain an intermediate formulation.
- encapsulation of the contents in the film forming composition can be carried out according to a conventionally known method for producing a soft capsule preparation, for example, a flat plate method or a rotary die method.
- the intermediate preparation obtained in the molding step is dried. Through this process, a soft capsule preparation which is a finished product can be obtained.
- the drying means to be applied to the drying step is not particularly limited, and a known dryer such as a tumble dryer (i.e., a rotary drum dryer) can be used.
- a known dryer such as a tumble dryer (i.e., a rotary drum dryer) can be used.
- the conditions such as temperature and time at the time of drying are not particularly limited, and can be appropriately adjusted depending on the components contained in the food composition and the components contained in the capsule film.
- the shape of the soft capsule preparation is not particularly limited, and any shape such as oval (OVAL), rectangular (OBLONG), spherical (ROUND) and the like can be employed. Methods or devices well known in the art can be applied to these shapes.
- the oil-in-water emulsion composition of the present disclosure can be diluted into a beverage using a solvent such as water.
- a solvent such as water may be added to the oil-in-water emulsion composition of the present disclosure, which is a solid preparation such as powder, to make a beverage.
- the oil-in-water emulsion composition of the present disclosure can be contained preferably in an amount of 0.0001% by mass to 50% by mass, more preferably 0.1% by mass to 20% by mass It can contain mass%.
- the taste and the like as a beverage can be appropriately adjusted by blending a sweetener, a flavor, an acidulant, a thickening stabilizer, an antioxidant and the like into the beverage.
- the sweetening agent may be any material that exhibits sweetness.
- fruit juice, sugars or high-intensity sweeteners may be mentioned.
- saccharides monosaccharides such as glucose, fructose, galactose and isomeric fructose, disaccharides such as sucrose, lactose and palatinose, fructooligosaccharides, isomaltooligosaccharides, galactooligosaccharides, oligosaccharides such as palatinose, for example, erythritol, sorbitol, xylitol, Monosaccharide alcohols such as mannitol, disaccharide alcohols such as maltitol, isomaltitol, lactitol, trisaccharide alcohols such as maltotriitol, isomaltotriitol, panitol, tetrasaccharide or more alcohols such as oligosaccharide alcohol And sugar alcohols such as
- Examples of the flavor include natural flavors and synthetic flavors and the like.
- Examples of the natural flavor include grass roots, wood peels, flowers, fruits, peels, and other ingredients containing fragrant ingredients prepared according to a conventional method using animal and plant as materials.
- separated the natural raw material by the steam distillation method, the expression method, the extraction method, etc. are mentioned.
- Examples of the synthetic flavor include coffee-derived flavor, black tea-derived flavor, green tea-derived flavor, oolong tea-derived flavor, cocoa-derived flavor, herb-derived flavor, spice-derived flavor, fruit-derived flavor and the like.
- the beverage may be a container-packed beverage by filling the container.
- a container used for a drink what is used as a container for drinks should just be used, for example, a PET bottle, a paper pack, a glass container, an aluminum can, a steel can etc. is mentioned.
- the pH of the beverage at 20 ° C. is preferably in the range of 1.0 to 9.0, more preferably in the range of 1.5 to 7.0, and particularly preferably in the range of 2.0 to 5.0. If it is pH 1.0 or more, it is preferable for drinking, and if it is pH 9.0 or less, the flavor stabilization effect as a drink can fully be acquired.
- oil-in-water emulsion composition of the present disclosure will be described in detail by examples.
- the oil-in-water emulsion compositions of the present disclosure are not limited in any way to those examples.
- “%” and “part” are mass references.
- the oil-in-water emulsion composition prepared in the examples can be suitably used for soft capsule formulations, foods (functional foods, health foods, beverages, etc.), medicines, quasi drugs, or cosmetics.
- Examples 1A to 11A, Comparative Examples 1A to 4A 1A. Preparation of Oil-in-Water Emulsion Composition
- Each component was mixed and dissolved according to the compositions shown in Table 1 and Table 2 to obtain an aqueous phase composition and an oil phase composition, respectively.
- the obtained aqueous phase composition and oil phase composition were mixed with stirring using a magnetic stirrer to obtain a mixture. Furthermore, while continuing stirring with a stirrer, the mixture is heated to 70 ° C. for 30 minutes, and then a shear force is applied for 3 minutes at 3000 rpm (revolutions per minute, the same applies hereinafter) using a TK homomixer (Primix Inc.) An oil-in-water emulsion composition was prepared.
- the obtained oil-in-water emulsion composition is treated three times at a pressure of 200 MPa with a Starburst mini machine (Sugino Machine Co., Ltd.) which is a high pressure dispersing device to obtain Examples 1A to 11A and Comparative Examples 1B to 4B.
- a Starburst mini machine Sudno Machine Co., Ltd.
- -Astaxanthin ASTOTS (registered trademark)-S (trade name, astaxanthin-containing oil derived from Haematococcus algae, containing 20% by mass of astaxanthin, medium-chain fatty acid triglyceride, Fujifilm Corporation)
- Tri capryl capric acid
- glyceryl O. D.
- each component in Table 1 and Table 2 represents the content rate (mass%) of each component.
- the description of “ ⁇ ” in the content of each component indicates that the corresponding component is not contained.
- Emulsification stability at room temperature After the oil-in-water emulsion composition was prepared and stored at 60 ° C. for 1 week, the presence or absence of precipitation in the oil-in-water emulsion composition was visually observed and evaluated according to the evaluation criteria shown below. .
- the storage period of 1 week at 60 ° C. corresponds to a storage period of about 1 year at room temperature (25 ° C.).
- a and B are levels without a problem in practical use.
- oil-in-water emulsion compositions of Examples 1A to 11A were all oil-in-water emulsion compositions in which the odor derived from the raw material of astaxanthin was suppressed and the emulsion stability at room temperature was also excellent.
- Viscosity of oil-in-water emulsion composition After preparation of the oil-in-water emulsion composition, the viscosity (mPa ⁇ s) at 25 ° C. was measured using a vibration viscometer (model number: VM-10A-L, As One Corporation). It was measured.
- the oil-in-water emulsion compositions of Examples 1A to 11A were all oil-in-water emulsion compositions which were also excellent in emulsion stability at low temperatures.
- high pressure emulsification was possible, and the production suitability was excellent.
- Examples 3A to 5A and 7A to 11A having a viscosity of 600 mPa ⁇ s or less can be processed for three or more passes, and are more preferable in producing an oil-in-water emulsion having a small particle size.
- Examples 1B to 12B, Comparative Example 1B 1B. Preparation of Oil-in-Water Emulsion Composition
- Each component was mixed and dissolved according to the composition shown in Table 4 to obtain an aqueous phase composition and an oil phase composition, respectively.
- activated carbon treatment was performed for the oil phase composition. The presence or absence of the activated carbon treatment is described in Table 4.
- the obtained aqueous phase composition and oil phase composition were mixed with stirring using a magnetic stirrer to obtain a mixture. Furthermore, while continuing stirring with a stirrer, the mixture is heated to 70 ° C.
- Hematococcus algae pigment 1 Hematococcus algae pigment 1: ASTOTS (registered trademark) -S (trade name, astaxanthin-containing oil derived from Hematococcus algae, color value 2000 to 5000, containing 20 mass% astaxanthin, medium-chain fatty acid triglyceride containing, 2,4-heptadienal Content of A: 6.2 mg / kg, concentration 1% by mass Astaxanthin-containing oil-in-water emulsion content per 100 parts by mass of 2,4-heptadienal content (B): 31.0 mg / kg, Fujifilm ( stock)).
- ASTOTS registered trademark
- S trade name, astaxanthin-containing oil derived from Hematococcus algae, color value 2000 to 5000, containing 20 mass% astaxanthin, medium-chain fatty acid triglyceride containing, 2,4-heptadienal Content of A: 6.2 mg / kg, concentration 1% by mass Astaxanthin-
- Hematococcus algae pigment 2 Hematococcus algae pigment 2: ASTOTS (registered trademark)-SS (trade name, astaxanthin-containing oil derived from Hematococcus algae, color value 5000 to 7500, containing 35 mass% astaxanthin, containing medium-chain fatty acid triglyceride, 2,4-heptadienal Content A: 2,4-Heptadienal content (B): 12.9 mg / kg, converted to 100 parts by mass of astaxanthin-containing oil-in-water emulsion containing 4.5 mg / kg, concentration 1 mass%, Fujifilm ( stock)) Tri (capryl capric acid) glyceryl: O. D.
- ASTOTS registered trademark
- SS trade name, astaxanthin-containing oil derived from Hematococcus algae, color value 5000 to 7500, containing 35 mass% astaxanthin, containing medium-chain fatty acid triglyceride, 2,4-heptadienal
- each component in Table 4 represents the content rate (mass%) of each component.
- the description of “ ⁇ ” in the content of each component indicates that the corresponding component is not contained.
- each calibration curve preparation sample solution is collected and enclosed in a head space vial to prepare a calibration curve preparation sample, and a head space gas chromatograph mass spectrometer (HS / GC-MS: Head Space-Gas Chromatograph / The peak area was measured using a Mass Spectrometer. The measuring device and the measuring conditions are shown below. Subsequently, the peak area corresponding to the concentration of 2,4-heptadienal of each calibration curve preparation sample was plotted to prepare a calibration curve.
- HS / GC-MS Head Space-Gas Chromatograph /
- HS part HS-20, Shimadzu Corp.
- GC-MS part GSMS-QP 2020, Shimadzu Corp.
- Example 2B The odor of the oil-in-water emulsion compositions of Example 2B, Example 7B, and Comparative Example 1B was evaluated by 12 experts who satisfied the criteria for panel selection shown below. Specifically, each oil-in-water emulsion composition of Example 2B, Example 7B and Comparative Example 1B is allowed to stand at room temperature (25 ° C.) to return the sample temperature to room temperature, and then it is made to drink by specialized panelists. The arithmetically averaged mean value was used. The results are shown in Table 5.
- ⁇ Criteria for panel selection> It is judged as a normal smell person by the standard odor for panel selection [Daiichi Pharmaceutical Industry Co., Ltd.], and 0.4% sucrose, 0.02% citric acid, 0.13% sodium chloride, 0.05% sodium glutamate and Those who can correctly identify the taste of an aqueous solution of 0.03% caffeine.
- Example 2B and Example 7B which contain a water-soluble tea extract which reduces the 2,4-heptadienal content (A) and contains 20% by mass or more of tea polyphenol
- the odor evaluation by the expert panelist was better than Comparative Example 1B in which the heptadienal content A was not reduced.
- Example 2B in which the content (B) of 2,4-heptadienal converted to 100 parts by mass of a 1% by mass astaxanthin-containing oil-in-water emulsion was reduced was a better evaluation result.
- the above results also show that the content of 2,4-heptadienal correlates with the degree of odor perceived by humans.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Edible Oils And Fats (AREA)
- General Preparation And Processing Of Foods (AREA)
- Non-Alcoholic Beverages (AREA)
- Cosmetics (AREA)
Abstract
Description
しかしながら、アスタキサンチンを食品原料とした場合、水への溶解性が低いため消化吸収性が悪い他、原料由来の特有の匂いによる商品の嗜好性の低下等の欠点も有している。
本発明の実施形態の一つは、アスタキサンチンの原料由来の臭気を抑制し、かつ乳化安定性に優れた水中油型乳化組成物を含有する、食品又は飲料を提供することを課題とする。
[1] アスタキサンチン、油性成分、酵素分解レシチン、ショ糖脂肪酸エステル、水溶性茶抽出物、及び水を含み、水溶性茶抽出物が、水溶性茶抽出物の全質量に対して茶ポリフェノールを20質量%以上含有し、水中油型乳化組成物の全質量に対するアスタキサンチンの含有率が0.1質量%~20.0質量%であり、水中油型乳化組成物の全質量に対する水溶性茶抽出物の含有率が0質量%超20.0質量%以下である、水中油型乳化組成物。
[2] さらに、ポリグリセリン脂肪酸エステルを含む、[1]に記載の水中油型乳化組成物。
[3] 乳化剤として、ポリグリセリン脂肪酸エステル、ショ糖脂肪酸エステル及び酵素分解レシチンからなる群から選ばれる1種以上のみを含有する、[1]に記載の水中油型乳化組成物。
[4] ポリグリセリン脂肪酸エステルを含有し、水中油型乳化組成物の全質量に対するポリグリセリン脂肪酸エステルの含有率が2質量%以上22質量%以下の範囲である、[2]又は[3]に記載の水中油型乳化組成物。
[5] 水溶性茶抽出物が水相に含まれる、[1]~[4]のいずれか1つに記載の水中油型乳化組成物。
[6] ショ糖脂肪酸エステルは、ショ糖脂肪酸エステルの全質量に対するモノ置換体の割合が75質量%以上である、[1]~[5]のいずれか1つに記載の水中油型乳化組成物。
[7] ショ糖脂肪酸エステルを水中油型乳化組成物の全質量に対して0.01質量%以上10質量%以下の範囲で含有する、[1]~[6]のいずれか1つに記載の水中油型乳化組成物。
[8] 酵素分解レシチンを水中油型乳化組成物の全質量に対して0.00001質量%以上7質量%以下の範囲で含有する、[1]~[7]のいずれか1つに記載の水中油型乳化組成物。
[9] さらにグリセリンを水中油型乳化組成物の全質量に対して20質量%以上50質量%以下の範囲で含有する、[1]~[8]のいずれか1つに記載の水中油型乳化組成物。
[10] 水溶性茶抽出物が水溶性茶抽出物の全質量に対して茶ポリフェノールを80質量%以上含有する、[1]~[9]のいずれか1つに記載の水中油型乳化組成物。
[11] 油性成分が、中鎖脂肪酸トリグリセライド及び動植物性油脂からなる群より選ばれる少なくとも1種である、[1]~[10]のいずれか1つに記載の水中油型乳化組成物。
[12] 食品添加物用途である、[1]~[11]のいずれか1つに記載の水中油型乳化組成物。
[13] [1]~[12]のいずれか1つに記載の水中油型乳化組成物を含む食品。
[14] [1]~[12]のいずれか1つに記載の水中油型乳化組成物を含む飲料。
また、本発明の実施形態の一つによれば、アスタキサンチンの原料由来の臭気を抑制し、かつ乳化安定性に優れたアスタキサンチン含有水中油型乳化組成物を含有する食品又は飲料を提供することができる。
本開示中に段階的に記載されている数値範囲において、ある数値範囲で記載された上限値又は下限値は、他の段階的な記載の数値範囲の上限値又は下限値に置き換えてもよい。また、本開示中に記載されている数値範囲において、ある数値範囲で記載された上限値又は下限値は、実施例に示されている値に置き換えてもよい。
本開示において、各成分の量は、各成分に該当する物質が、組成物中に複数種存在する場合には、特に断らない限り、組成物中に存在する複数種の物質の合計量を意味する。
本開示において、2以上の好ましい態様の組み合わせは、より好ましい態様である。
使用する成分が市販品ではない場合、或いは、市販であってもHLB値がカタログ等の文献に明確に示されていない場合には、本開示におけるHLB値としては、以下に示す川上式を採用する。
ここで、Mwは親水基の分子量、M0は疎水基の分子量である
本開示の実施形態の一つは、本開示の水中油型乳化組成物を含む食品又は飲料(以下、単に「本開示の食品」又は「本開示の飲料」と称することがある。)である。
本開示の水中油型乳化組成物は、水中油型乳化組成物の全質量に対して0.1質量%~20.0質量%の含有率であるアスタキサンチンと、油性成分と、酵素分解レシチンと、ショ糖脂肪酸エステルと、水中油型乳化組成物の全質量に対して0質量%超20.0%以下の含有率であり、水溶性茶抽出物の全質量に対して茶ポリフェノールを20質量%以上含む水溶性茶抽出物と、水とを含む、水中油型乳化組成物である。
ができる。
本開示において室温とは「25±3℃」を指す。
一般的に、茶抽出物は、消臭効果を有することが知られている。しかしながら、本発明者の検討によると、アスタキサンチンの原料由来の臭気を低減させるために、茶抽出物を水中油型乳化組成物に含有させた場合、室温経時に伴う水中油型乳化組成物の安定性が悪化することがわかった。本発明者が検討を重ねたところ、茶抽出物の中でも茶ポリフェノールを20質量%以上含む水溶性茶抽出物を特定量で含み、さらに、油性成分、酵素分解レシチン、およびショ糖脂肪酸エステルを含む水中油型乳化組成物とすることにより、高濃度のアスタキサンチンを含みながらも、アスタキサンチンの原料由来の臭気が抑制され、かつ、優れた乳化安定性を示すことが明らかとなった。
本開示において冷蔵保存とは、「1℃超10℃以下」の雰囲気温度における保存を指す。また、本開示において冷蔵保存と低温保存とは同義である。
本開示の水中油型乳化組成物は、アスタキサンチンを含む。
本開示の水中油型乳化組成物は、アスタキサンチンを含む。本開示では、特に断りの無い限り、アスタキサンチン及びその誘導体を総称して「アスタキサンチン」という。すなわち、本開示の水中油型乳化組成物では、アスタキサンチンとして、アスタキサンチン及びその誘導体からなる群より選ばれる少なくとも1種を含む。アスタキサンチンの誘導体は、アスタキサンキチンのエステル等を含む。
アスタキサンチンは、赤色酵母ファフィア、緑藻ヘマトコッカス、海洋性細菌、オキアミ等の培養物から抽出することができる。
品質及び生産性の観点からは、アスタキサンチンとしては、ヘマトコッカス藻からの抽出物(以下、「ヘマトコッカス藻抽出物」と称する。)又はオキアミからの抽出物に由来するアスタキサンチンが好ましく、ヘマトコッカス藻抽出物に由来するアスタキサンチンが特に好ましい。
本開示の水中油型乳化組成物では、アスタキサンチンは、後述する油性成分に溶解された状態であることが好ましい。すなわち、アスタキサンチンは、油性成分にアスタキサンチンを含有させたアスタキサンチン含有油の態様で、本開示の水中油型乳化組成物に配合することができる。
これらの中でも、ヘマトコッカス藻としては、ヘマトコッカス・プルビアリス(Haematococcus pluvialis)が好ましい。
ヘマトコッカス藻抽出物の市販品の例としては、富士フイルム(株)のASTOTS(登録商標)-S、ASTOTS(登録商標)-5O、ASTOTS(登録商標)-10O等、富士化学工業(株)のアスタリール(登録商標)オイル50F、アスタリール(登録商標)オイル5F等、東洋酵素化学(株)のBioAstin SCE7などが挙げられる。
なお、ヘマトコッカス藻抽出物は、特開平2-49091号公報に記載の色素と同様に、色素純分として、アスタキサンチン又はそのエステル体を含有してもよい。
アスタキサンチンの含有率は、例えば、アスタキサンチンを含むことで期待される効果を十分に得る観点から、水中油型乳化組成物の全質量に対して、0.2質量%以上であることが好ましく、0.4質量%以上であることがより好ましく、1.0質量%以上であることがさらに好ましい。
また、アスタキサンチンの含有率は、例えば、摂取のしやすさの観点から、水中油型乳化組成物の全質量に対して、10質量%以下であることが好ましく、8質量%以下であることがより好ましい。
本開示の水中油型乳化組成物は、油性成分を含有する。
本開示の水中油型乳化組成物において油性成分とは、25℃の水への溶解度が0.1質量%未満(1g/L未満)の成分である。油性成分は、アスタキサンチンを溶解する目的で使用する化合物として好適に用いることができる。アスタキサンチンは、本開示の水中油型乳化組成物における油性成分には包含されない。
中鎖脂肪酸トリグリセライドの例としては、トリグリセライドを構成する脂肪酸の炭素数が8~10である中鎖脂肪酸トリグリセリドが挙げられる。
動植物性油脂としては、例えば、大豆油、菜種油、綿実油、ひまわり油、サフラワー油、やし油、小麦胚芽油、コーン胚芽油、オリーブ油、米ぬか油、ココナッツ油等の植物性油脂、肝油、魚油、鯨油等の動物性油脂が挙げられる。
これらの油性成分のなかでも、中鎖脂肪酸トリグリセライドが好ましく、本開示の水中油型乳化組成物が含有する油性成分としては、中鎖脂肪酸トリグリセライドのみであることがより好ましい。
本開示の水中油型乳化組成物は、水中油型乳化組成物の全質量に対して0質量%超2.0質量%以下の含有率である水溶性茶抽出物を含有する。
本開示の水中油型乳化組成物に用いる水溶性茶抽出物は、25℃の水への溶解度が20質量%以上(200g/L以上)の茶抽出物であれば特に制限はない。
水溶性茶抽出物は、緑茶、ウーロン茶、及び紅茶から選択される茶葉のうち一種又は二種以上から抽出されたものであり、茶ポリフェノール(カテキン類)を水溶性茶抽出物の全質量に対して20質量%以上含む。抽出に用いる溶剤(「抽出溶剤」とも言う。)は、特に限定されず、熱水、メタノール、エタノール、イソプロパノール、酢酸エチルなどが挙げられる。これらの抽出溶剤の1種又は2種以上の混合物を用いて抽出操作を行なうことで、水溶性茶抽出物を含む抽出液が得られる。
抽出液は熱水抽出の場合はそのままでも使用でき、望ましくは噴霧乾燥や凍結乾燥などにより水を除去した粉末状のものが使用しやすく、デキストリン、グリセリン等で製剤化したものも用いることができる。
臭気を低減する観点から、抗酸化剤Aの含有率の下限は、水中油型乳化組成物の全質量に対して好ましくは0.1質量%以上、より好ましくは0.3質量%以上である。
一方、アスタキサンチンによる水中油型乳化組成物の粘度を低減させ、製造適性を良好とする観点から、抗酸化剤Aの含有率の上限は特に制限されないが、乳化安定性の観点からは20.0質量%以下であり、好ましくは15.0質量%以下であり、より好ましくは10.0質量%以下であり、さらに好ましくは8.0質量%以下であり、よりさらに好ましくは5.0質量%以下である。
この点について、本発明者は、抗酸化剤Aが水相中に含まれる場合、水中油型組成物において、油相の界面に存在するために、連続相である水相へ臭気が拡散することを押さえ込んでいるためと考えている。
本開示の水中油型乳化組成物は、上述した水溶性茶抽出物(抗酸化剤A)とは異なる抗酸化剤(以下、「抗酸化剤B」とも称する。)を少なくとも1種含有してもよい。
抗酸化剤Bとしては、特に限定されない。
抗酸化剤Bとしては、例えば、アスコルビン酸、アスコルビン酸誘導体、及びそれらの塩からなる群より選択される少なくとも1種の化合物、トコフェロール等のビタミンE及びその誘導体、ビタミンA、レチノイン酸、レチノール、酢酸レチノール、パルミチン酸レチノール、レチニルアセテート、レチニルパルミテート、レチノイン酸トコフェリル、ビタミンC及びその誘導体、カイネチン、レチノイン、セサミン、α-リポ酸、コエンザイムQ10、フラボノイド類、エリソルビン酸、没食子酸プロピル、BHT(ジ-n-ブチルヒドロキシトルエン)、BHA(ブチルヒドロキシアニソール)、トレチノイン、ポリフェノール、SOD(スーパーオキサイドディスムターゼ)、フィチン酸、コウキエキス、大豆エキス、エイジツエキス、ローズマリーエキスなどを挙げることができる。
抗酸化剤Bの含有量は、アスタキサンチンの質量に対して、0.1倍量以上100倍量以下であることが好ましく、0.1倍量以上10倍量以下であることがより好ましく、0.1倍量以上5倍量以下であることが更に好ましい。
また、アスコルビン酸誘導体及びその塩としては、アスコルビン酸リン酸エステル及びその塩、アスコルビン酸硫酸エステル及びその塩、パルミチン酸アスコルビルリン酸エステル及びその塩等が挙げられる。
本開示の水中油型乳化組成物において抗酸化剤Bとして、アスコルビン酸、アスコルビン酸誘導体、及びそれらの塩からなる群より選択される少なくとも1種の化合物、及び/又は、トコフェロール等のビタミンE及びその誘導体が含有される場合、その総含有率は、本開示の水中油型乳化組成物の全質量に対して0.5質量%~6質量%であることが好ましく、これらの化合物の低温における経時での析出を抑制する点から、0.5質量%~4質量%がより好ましく、0.5質量%~3質量%が更に好ましい。
本開示の水中油型乳化組成物は、酵素分解レシチンを含む。
レシチンは、ホスファチジルコリン(PC)などの各種のリン脂質を含有する混合物の一般的な名称である。酵素分解レシチン(リゾレシチンとも呼ばれる)は、ホスホリパーゼなどの酵素により、ホスファチジルコリン分子が持つ1つの脂肪酸が失われたリゾホスファチジルコリンを含有する組成物である。なお、本開示の水中油型乳化組成物において、酵素分解レシチンは、水素添加処理を行い、結合脂肪酸を飽和脂肪酸にすることで酸化安定性を向上させた、いわゆる水素添加された酵素分解レシチンを含む。
本開示の水中油型乳化組成物は、ショ糖脂肪酸エステルを含む。本開示の水中油型乳化組成物は、ショ糖脂肪酸エステルを含むことにより、アスタキサンチンの体内での吸収性が向上し、経時に伴う乳化安定性が向上する。
本開示の水中油型乳化組成物は、ショ糖脂肪酸エステルを1種単独で含んでもよく、2種以上組み合わせて含んでもよい。
また、ショ糖脂肪酸エステルのHLB値は、両親媒性を示す観点から、好ましくは19以下である。
ショ糖脂肪酸エステルの具体例としては、ショ糖ラウリン酸エステル、ショ糖ミリスチン酸エステル、ショ糖パルミチン酸エステル、ショ糖ステアリン酸エステル、ショ糖オレイン酸エステル等が挙げられる。
ショ糖ステアリン酸エステルにおけるモノエステル体の含有率は、以下の方法により測定することができる。
<試料の調製>
ショ糖ステアリン酸エステルを、1mg/mLとなる量でテトラヒドロフランへ添加し、溶解して試料溶液を得る。
<測定条件>
使用装置: 高速液体クロマトグラフィー prominence (株式会社島津製作所)
検出方法: コロナ荷電化粒子検出
カラム: Capcellpack C18 UG120 4.6mm×150mm(株式会社資生堂)
カラム温度: 40℃
溶離液: 0分~20分:水/メタノール50/50、7mM酢酸アンモニウム;20分~30分:メタノール、7mM酢酸アンモニウム
流量: 1mL/min
注入量: 10μL
高速液体クロマトグラフィーにおける保持時間15分~30分におけるピーク総面積に対する保持時間17分~22分におけるピーク面積の割合を算出し、これをモノエステル体の含有率とする。
なかでも、リョートーシュガーエステルS-1170、S-1170F、S-1570、S-1670、DKエステルSS、F160、F140、F110、コスメライクS-110、S-160、S-19等が好ましい。モノエステル体の含有量の比率が高いことから、DKエステルSSのみからなることが最も好ましい。
また、ショ糖脂肪酸エステルの含有率は、例えば、乳化安定性の観点から、水中油型乳化組成物の全質量に対して、10質量%以下であることが好ましい。
本開示の水中油型乳化組成物は、より好ましくはポリグリセリン脂肪酸エステルを含む。
ポリグリセリン脂肪酸エステルとしては、炭素数10以上の飽和肪酸構造、分岐脂肪酸構造及び不飽和脂肪酸構造の少なくとも1つを有するポリグリセリン脂肪酸エステルであることが好ましい。
本開示におけるポリグリセリン脂肪酸エステルとしては、平均重合度が好ましくは6~20、より好ましくは8~16、さらに好ましくは8~10のポリグリセリンと、炭素数10~22の飽和脂肪酸、炭素数8~22の不飽和脂肪酸及び炭素数8~22の分岐飽和脂肪酸から選ばれる脂肪酸のエステルが挙げられる。なお、炭素数10~22の飽和脂肪酸には、炭素数10~22の直鎖状飽和脂肪酸及び炭素数10~22の分岐不飽和脂肪酸が含まれ、炭素数8~22の不飽和脂肪酸には、炭素数8~22の直鎖状不飽和脂肪酸及び炭素数8~22の分岐不飽和脂肪酸が含まれる。
ポリグリセリンの重合度が上記範囲にあることで、乳化安定性がより良好となる。
ポリグリセリン脂肪酸エステルとしては、炭素数10~22の飽和脂肪酸構造、炭素数8~22の不飽和脂肪酸構造及び炭素数8~22の分岐飽和脂肪酸構造から選ばれる脂肪酸構造を有するエステルが好ましく、炭素数10~22の飽和脂肪酸構造、炭素数16~22の分岐脂肪酸構造及び炭素数16~22の不飽和脂肪酸構造の少なくとも1つを有する脂肪酸のエステルがより好ましく、炭素数10~20の飽和脂肪酸構造、炭素数16~18の分岐脂肪酸構造及び炭素数16~18の不飽和脂肪酸構造の少なくとも1つを有する脂肪酸のエステルがさらに好ましい。
炭素数10~22の飽和脂肪酸から選ばれる脂肪酸としては、例えば、ラウリン酸、ミリスチン酸、パルミチン酸及びステアリン酸が挙げられる。
炭素数8~22の不飽和脂肪酸及び炭素数8~22の分岐飽和脂肪酸から選ばれる脂肪酸としては、例えば、オレイン酸、リノール酸及びイソステアリン酸が挙げられる。
また、ポリグリセリン脂肪酸エステルは、界面活性能を有する。乳化安定性をより向上させる観点から、HLBが5以上の化合物が好ましく、8以上の化合物がより好ましく、10以上の化合物がさらに好ましい。一方、ポリグリセリン脂肪酸エステルのHLBの上限値は、特に限定されないが、20以下が好ましく、18以下がより好ましい。
本開示の水中油型乳化組成物におけるポリグリセリン脂肪酸エステルの含有率は、水中油型乳化組成物の全質量に対して、2質量%~22質量%であることが好ましく、5質量%~22質量%であることがより好ましい。
水中油型乳化組成物におけるポリグリセリン脂肪酸エステルの含有量が上記範囲において、均一でありかつ微細な油相粒子が得やすく、水中油型乳化組成物の低温における乳化安定性がより良好となる。
本開示の水中油型乳化物は、水を含む。
水としては、特に制限はなく、天然水、精製水、蒸留水、イオン交換水、純水、超純水(Milli-Q水等)などを使用することができる。なお、Milli-Q水とは、メルク(株)メルクミリポアのMilli-Q水製造装置により得られる超純水である。
本開示の水中油型乳化組成物は、乳化剤を含有することが好ましい。
本開示の水中油型乳化組成物における乳化剤としては、既述した、酵素分解レシチン、ショ糖脂肪酸エステル及びポリグリセリン脂肪酸エステルからなる群から選択される1種以上のみを含有することが好ましいが、本開示の水中油型乳化組成物に期待される効果を損なわない限りにおいて、他の乳化剤を含有してもよい。
他の乳化剤としては、天然物由来の乳化剤のみを用いて高圧乳化を行えること、及び経時安定性の観点から、酵素分解レシチン以外のレシチン、サポニン、ステロール等を含有してもよい。
ここで、「乳化剤として、酵素分解レシチン、ショ糖脂肪酸エステル及びポリグリセリン脂肪酸エステルからなる群から選択される1種以上のみを含有する」とは、酵素分解レシチン、ショ糖脂肪酸エステル及びポリグリセリン脂肪酸エステル以外の他の乳化剤の含有率が、水中油型乳化組成物の全質量に対し、1質量%以下であることを指す。他の乳化剤の含有率は、0.001質量%以上1質量%以下であることが好ましく、0.01質量%以上1質量%以下であることがより好ましく、0.01質量%以上0.5質量%以下であることがさらに好ましい。
本開示の実施形態の水中油型乳化組成物は、多価アルコールを含むことが好ましい。乳化安定性の観点から、多価アルコールとしては、グリセリン、ソルビトール及び還元水飴からなる群より選ばれる少なくとも1種であることが好ましく、グリセリン又は還元水飴から選択される少なくとも1種であることがより好ましい。
グリセリンは、アスタキサンチンを含む乳化粒子の平均粒子径を小さくし、かつ粒子径を小さいまま長期にわたり安定に保持し易くなることから、好ましく用いられる。
還元水飴は、糖アルコールの1種であり、水飴を還元(すなわち水素添加)することで合成される。還元水飴は、原料となる水飴(すなわち糖類)の組成を変更することによって粘度を調整することができ、高糖化還元水飴と低糖化還元水飴とに分類される。
アスタキサンチンを含む乳化粒子の平均粒子系を小さくし、かつ粒子径を小さいまま長期にわたり安定に保持しやすくなることから、低糖化還元水飴が好ましく用いられる。
還元水飴の市販品の例としては、オリゴトース(三和澱粉工業(株))、オリゴトース(商品名、物産フードサイエンス(株))、エスイー30(商品名、物産フードサイエンス(株))、エスイー100(商品名、物産フードサイエンス(株))オリゴトース H―70(三菱化学フーズ(株))、ハローデックス(商品名、(株)林原)、テトラップ、テトラップ-H(商品名、(株)林原)、ペントラップ(商品名、(株)林原)、カップリングシュガー(商品名、(株)林原)、カップリングシュガーS(商品名、(株)林原)等が挙げられる。
市販品の液体状の還元水飴は、20質量%以上40質量%以下の水を含むことが多いが、所望の効果が得られる限り、この範囲以外の水を含むものであってもよい。
なお、本開示でいう「水中油型乳化組成物における還元水飴の含有率」とは、水中油型乳化組成物中に含まれている還元水飴の固形分の質量基準の含有率を意味する。
本開示の水中油型乳化組成物は、上述した各成分の他に、必要に応じて任意の他の成分を、1種又は2種以上含有していてもよい。その他の成分としては、例えば、栄養成分、有効成分、薬理成分等のアスタキサンチン以外の生理活性成分、色素(アスタキサンチンは含まない)、酸化防止剤、水飴等の液糖などが挙げられる。このようなその他の成分としては、飲食品、医薬品に使用可能なものであれば、特に制限されない。
本開示の水中油型乳化組成物は、アスタキサンチン及び油性成分を含む油相組成物と、水、ショ糖脂肪酸エステル及び酵素分解レシチンを含む水相組成物とを混合した混合液を調製し、調製された混合液を常法により乳化することを含む製造方法により、製造されることが好ましい。水溶性茶抽出物(抗酸化剤A)は油相組成物および水相組成物のどちらが含有してもよいが、臭気を効果的に抑制する観点から、水相組成物が含有することが好ましい。
本開示の水中油型乳化組成物は、抗酸化剤Aを含有するため、高濃度のアスタキサンチンを含有しつつも、水中油型乳化組成物の粘度の上昇を低減することができるため、製造適性に優れている。
乳化に供される混合液は、油相組成物及び水相組成物をそれぞれ別個に調製した後、調製された油相組成物及び水相組成物を組み合わせて調製してもよいし、油相組成物及び水相組成物に含まれる各成分を、一括に混合して又は逐次混合して調製してもよい。
均質バルブ型高圧ホモジナイザーは、処理液の流路の幅を容易に調節することができるので、操作時の圧力及び流量を任意に設定することができ、その操作範囲が広いため、本開示の水中油型乳化組成物の製造において好ましく用いることができる。
操作の自由度は低いが、圧力を高める機構が作りやすいため、超高圧を必要とする用途にはチャンバー型高圧ホモジナイザーも好適に用いることができる。
均質バルブ型高圧ホモジナイザーとしては、ゴーリンタイプホモジナイザー(APV社製)、ラニエタイプホモジナイザー(ラニエ社製)、高圧ホモジナイザー(ニロ・ソアビ社製)、ホモゲナイザー(三和機械(株)製)、高圧ホモゲナイザー(イズミフードマシナリ(株)製)、超高圧ホモジナイザー(イカ社製)等が挙げられる。
得られた水中油型乳化組成物は、チャンバー通過直後30秒以内、好ましくは3秒以内に何らかの冷却器を通して冷却することが、乳化粒子の粒子径保持の観点から好ましい。
アスタキサンチンの原料に由来する臭気は、複数の物質に由来し、その原因物質の1つとして、2,4-ヘプタジエナールが挙げられる。このため、臭気を低減する観点から、2,4-ヘプタジエナールの含有量(A)が水中油型乳化組成物の全質量に対して1000ppb以下が好ましく、800ppb以下がより好ましく、500ppb以下がさらに好ましい。
飲料等に加工した際ののど越し、特に藻臭(口に含んだ後の鼻から抜ける藻のような生臭又は魚臭さ)が軽減される観点からは、下記の式(1)に沿って算出する濃度1質量%アスタキサンチン含有水中油型乳化物100質量部あたりに換算した2,4-ヘプタジエナールの含有量(B)は200ppb以下が好ましく、100ppb以下がより好ましく、80ppb以下がさらに好ましい。
(B)=(A)/水中油型乳化組成物中のアスタキサンチン含有率・・・式(1)
2,4-ヘプタジエナールの含有量を低減させる方法は特に制限はなく、
(1)アスタキサンチンの原料そのものを公知の脱臭方法で精製した後、精製したアスタキサンチンを用いて本開示の水中油型乳化組成物を調整する方法、及び、
(2)本開示の水中油型乳化組成物を調整した後に、公知の脱臭方法で精製する方法、
等のいずれの方法であってもよい。
公知の脱臭方法としては、超臨界抽出方法、活性炭又はシリカゲル等の多孔質吸着剤を用いた分離精製方法、マスキング方法、オゾン酸化法、触媒燃焼法等が挙げられる。
なお、本開示において2,4-ヘプタジエナールとは、構造異性体を含む。
本開示の水中油型乳化組成物の粘度は、特に限定されないが、乳化分散等の製造適性の観点から、600mPa・s以下が好ましく、500mPa・s以下が好ましい。下限値は特に制限されないが、例えば、50mPa・s以上が挙げられる。
本開示の水中油型乳化組成物の平均粒子径(体積平均粒子径)は、特に限定されないが、5nm~200nmであることが好ましく、水中油型乳化組成物の良好な透明性と安定性の観点からは、10nm~150nmとすることがより好ましく、10nm~120nmとすることがさらに好ましい。
粒径測定は、動的光散乱法により行なうことが好ましい。動的光散乱法を用いた市販の測定装置としては、ナノトラックUPA(商品名、日機装(株))、動的光散乱式粒径分布測定装置LB-550(商品名、(株)堀場製作所)、濃厚系粒径アナライザーFPAR-1000(商品名、大塚電子(株))等が挙げられるが、動的光散乱法の原理に基づき、粒径測定が可能になるものであれば、測定装置はこれらに限定されない。
本開示の水中油型乳化組成物は、乾燥することにより、粉末化された形態とすることができる。
水中油型乳化組成物を粉末化する際の乾燥方法は、特に限定されず、噴霧乾燥、混練造粒、凍結乾燥など常法を用いることができる。
粉末化された水中油型乳化組成物は、水を含む溶媒に懸濁することにより、水中油型乳化組成物として利用することができる。
本開示の水中油型乳化組成物は、食品又は飲料(機能性食品又は飲料、健康食品又は飲料等)、医薬品、医薬部外品、化粧品等の各種の用途に適用することができ、なかでも、高濃度にアスタキサンチンを含有しつつも、アスタキサンチンの原料由来の臭気が低減することができるため、本開示の水中油型乳化組成物は、食品又は飲料に好ましく用いられ、特に飲料に好ましく用いることができる。
本開示の水中油型乳化組成物が適用される、食品、医薬品、医薬部外品、又は化粧品の剤型としては、例えば、液体製剤及びそれを乾燥して得られる固体製剤(散剤、顆粒剤等)が挙げられる。
本開示の水中油型乳化組成物の好適な適用形態の一つは、本開示の水中油型乳化組成物を含むソフトカプセル製剤である。即ち、本開示のソフトカプセル製剤は、本開示の水中油型乳化組成物を含む内容物をソフトカプセル皮膜に封入することによって得られる。
本開示のソフトカプセル製剤における内容物は、ソフトカプセル製剤の全量に対して、本開示の水中油型乳化組成物を、0.0001質量%~95質量%含むことができる。
また、ソフトカプセル皮膜は、可塑剤を含んでいてもよく、可塑剤としては、グリセリン;プロピレングルコール、ポリエチレングリコール等のグリコール類;コーンシロップ、スクロース、フルクトース、ソルビトール、マンニトール等の糖類;結晶セルロース、デンプン類、低置換度ヒドロキシプロピルセルロース、エチルセルロースなどの水不溶性セルロース等を挙げることができる。なお、これらの可塑剤は1種単独で使用しても、また2種以上を任意に組み合わせて使用することもできる。可塑剤としては、グリセリンが好ましい。
乾燥の際の温度、時間等の条件は、特に制限されるものではなく、食品組成物に含まれる成分及びカプセル皮膜に含まれる成分の種類により、適宜調整することができる。
本開示の水中油型乳化組成物は、水などの溶媒を用いて希釈して飲料にすることができる。
粉末等の固体製剤とした本開示の水中油型乳化組成物に、水などの溶媒を加えて飲料にしてもよい。
飲料とする場合は、飲料の全量に対して、本開示の水中油型乳化組成物を、好ましくは0.0001質量%~50質量%含むことができ、より好ましくは0.1質量%~20質量%含むことができる。
天然香料としては、例えば、草根、木皮、花、果実、果皮又はその他動植物を素材として常法に従って調製された香成分含有物等が挙げられる。また、天然香料としては、天然素材を、水蒸気蒸留法、圧搾法又は抽出法等によって処理して分離した精油等が挙げられる。
合成香料としては、例えば、コーヒー由来香料、紅茶由来香料、緑茶由来香料、ウーロン茶由来香料、ココア由来香料、ハーブ由来香料、スパイス由来香料、フルーツ由来香料等が挙げられる。
飲料に使用される容器としては、飲料用容器として使用されているものであればよく、例えば、PETボトル、紙パック、ガラス容器、アルミ缶、スチール缶等が挙げられる。
実施例において調製された水中油型乳化組成物は、ソフトカプセル製剤、食品(機能性食品、健康食品、飲料等)、医薬品、医薬部外品、又は化粧品に好適に利用できる。
1A.水中油型乳化組成物の調製
表1および表2に示す組成で各成分をそれぞれ混合し、溶解して、水相組成物及び油相組成物を、それぞれ得た。得られた水相組成物及び油相組成物を、マグネチックスターラーを用いて攪拌しながら混合して混合液を得た。
さらにスターラーで撹拌を続けながら、混合液を70℃に30分間加温した後、TKホモミキサー(プライミクス株式会社)を用いて3000rpm(revolutions per minute、以下同じ)で3分間剪断力を付与して、水中油型乳化組成物を調製した。
得られた水中油型乳化組成物を、高圧分散装置であるスターバーストミニ機((株)スギノマシン)で200MPaの圧力で3回処理することで、実施例1A~11Aおよび比較例1B~4Bの水中油型乳化組成物を得た。
・アスタキサンチン:ASTOTS(登録商標)-S(商品名、ヘマトコッカス藻由来アスタキサンチン含有油、アスタキサンチン20質量%含有、中鎖脂肪酸トリグリセライド含有、富士フイルム(株))
・トリ(カプリル・カプリン酸)グリセリル:O.D.O(商品名、日清オイリオ(株))
・酵素分解レシチン:SLPホワイトリゾ(商品名、辻製油(株))
・ショ糖脂肪酸エステル1:DKエステルSS(商品名、第一工業製薬(株))
・ショ糖脂肪酸エステル2:リョートーシュガーエステルS-1670(商品名、三菱化学フーズ(株))
・ポリグリセリン脂肪酸エステル:ポエムJ-0381V(商品名、理研ビタミン(株))
・ミックストコフェロール(ビタミンE混合物):理研Eオイル800(商品名、理研ビタミン(株))
・グリセリン:食品添加物グレード
・水溶性茶抽出物1:ポリフェノン70S(商品名、茶ポリフェノール80%含有、三井農林(株))
・水溶性茶抽出物2:サンフード100(商品名、三菱化学フーズ(株))
・水溶性抗酸化剤:L-アスコルビン酸ナトリウム(三菱化学フーズ(株))
・油溶性茶抽出物:サンフード油性(商品名、三菱化学フーズ(株))
・抗酸化剤B:ローズマリー抽出物(日清オイリオ(株))
・水: 精製水
表1及び表2中、各成分の含有量における「-」の記載は、該当する成分を含有していないことを示す。
得られた各水中油型乳化組成物を以下の方法で評価した。結果を表1及び表2に示す。
得られた水中油型乳化組成物をアスタキサンチンの濃度が6mg/100gとなるように、ミネラルウォーターに溶解させ、飲料組成物を調製した。
調製した飲料組成物を8人の被験者で飲用し、藻臭(口に含み、鼻から抜ける藻のような生臭又は魚臭さ)について、以下に示す評価段階の数値で評価した。得られた各人の数値を算術平均した平均値を、以下に示すA、B又はCにてランク付けし、評価結果とした。
<評価段階>
-2:藻臭がなく、飲みやすい。
0:藻臭が僅かにするが、飲める。
+2:藻臭が明らかにし、飲めない。
<平均値>
A:-1.0点以下
B:-1.0点超0.5点以下
C:0.5点超1.5点以下
D:1.5点超
水中油型乳化組成物を調製後、60℃で1週間保存した後、目視にて水中油型乳化組成物における沈殿の有無を観察し、以下に示す評価基準により評価した。
ここで、60℃で1週間の保存期間は、室温(25℃)で約1年間保存した期間に相当する。なお、A及びBは実用上問題のないレベルである。
A:水中油型乳化組成物中に沈殿は認められない。
B:水中油型乳化組成物中にわずかな浮遊物が認められる。
C:水中油型乳化組成物中に析出、沈殿が認められるか、相分離が認められる。
実施例1A~11Aの水中油型乳化組成物を以下の方法で評価した。結果を表3に示す。
水中油型乳化組成物を調製後、振動式粘度計(型番:VM-10A-L、アズワン(株))を用いて25℃での粘度(mPa・s)を測定した。
各水中油型乳化組成物について、高圧乳化装置(スターバーストミニ、スギノマシン(株)製)にて圧力200MPa、穴径0.15μmの噴射ノズルを用いたノズル噴射方式により何パス処理可能か確認した。以下に示す評価基準により評価した。
A:3パス以上可能。
B:2パス可能。
C:1パスは可能だが、2パス以上の処理がやや難しい。
水中油型乳化組成物を調製後、10℃で1ヶ月保存した後、目視にて水中油型乳化組成物における沈殿の有無を観察し、以下に示す基準により評価した。なお、A及びBは実用上問題のないレベルである、
A:水中油型乳化組成物中に沈殿は認められない。
B:水中油型乳化組成物中にわずかな浮遊物が認められる。
1B.水中油型乳化組成物の調製
表4に示す組成で各成分をそれぞれ混合し、溶解して、水相組成物及び油相組成物を、それぞれ得た。
油相組成物については、調製後、活性炭処理を実施した。活性炭処理の有無については表4中に記載をした。
得られた水相組成物及び油相組成物を、マグネチックスターラーを用いて攪拌しながら混合して混合液を得た。
さらにスターラーで撹拌を続けながら、混合液を70℃に30分間加温した後、TKホモミキサー(プライミクス株式会社)を用いて3000rpmで3分間剪断力を付与して、水中油型乳化組成物を調製した。
得られた水中油型乳化組成物を、高圧分散装置であるスターバーストミニ機((株)スギノマシン)で200MPaの圧力で3回処理することで、実施例1B~12B及び比較例1Bの水中油型乳化組成物を得た。
・ヘマトコッカス藻色素1:ASTOTS(登録商標)-S(商品名、ヘマトコッカス藻由来アスタキサンチン含有油、色価2000~5000、アスタキサンチン20質量%含有、中鎖脂肪酸トリグリセライド含有、2,4-ヘプタジエナール量の含有量A:6.2mg/kg、濃度1質量%アスタキサンチン含有水中油型乳化物100質量部あたりに換算した2,4-ヘプタジエナールの含有量(B):31.0mg/kg、富士フイルム(株))。
・ヘマトコッカス藻色素2:ASTOTS(登録商標)-SS(商品名、ヘマトコッカス藻由来アスタキサンチン含有油、色価5000~7500、アスタキサンチン35質量%含有、中鎖脂肪酸トリグリセライド含有、2,4-ヘプタジエナールの含有量A:4.5mg/kg、濃度1質量%のアスタキサンチン含有水中油型乳化物100質量部あたりに換算した2,4-ヘプタジエナールの含有量(B):12.9mg/kg、富士フイルム(株))
・トリ(カプリル・カプリン酸)グリセリル:O.D.O(商品名、日清オイリオ(株))
・酵素分解レシチン:SLPホワイトリゾ(商品名、辻製油(株))
・ショ糖脂肪酸エステル1:DKエステルSS(商品名、第一工業製薬(株))
・ポリグリセリン脂肪酸エステル1:Nikkol Decaglyn1-M(商品名、日光ケミカルズ(株)、デカグリセリンモノミリスチン酸エステル)
・ポリグリセリン脂肪酸エステル2:NikkolDecaglyn1-L(商品名、日光ケミカルズ(株)、デカグリセリンモノラウリン酸エステル)
・ミックストコフェロール(ビタミンE混合物):理研Eオイル800(商品名、理研ビタミン(株))
・グリセリン:食品添加物グレード
・水溶性茶抽出物1:ポリフェノン70S(商品名、茶ポリフェノール含有量:80%、うち、エピガロカテキンガレート含有量:20~30%、三井農林(株))
・水溶性茶抽出物2:Nテアフラン90S(商品名、茶ポリフェノール含有量:90%、うち、エピガロカテキンガレート含有量:40~50%、伊藤園(株))
・水溶性茶抽出物3:サンフェノンEGCG-OP(商品名、茶ポリフェノール含有量:95%、うち、エピガロカテキンガレート含有量:94%以上、太陽化学(株))
・水: 精製水
表4中、各成分の含有量における「-」の記載は、該当する成分を含有していないことを示す。
得られた各水中油型乳化組成物を以下の方法で評価した。結果を表4に示す。
上述した2A-1と同様の手順で評価した。
上述した2A-2と同様の手順で評価した。
実施例1B~12B及び比較例1Bの水中油型乳化組成物を以下の方法で評価した。結果を表4に示す。
上述した3A-1と同様の手順で評価した。
上述した3A-2と同様の手順で評価した。
上述した3A-3と同様の手順で評価した。
4B-1.2,4-ヘプタジエナールの含有量
実施例2B、7B及び比較例1Bの水中油型乳化組成物について、2,4-ヘプタジエナールの含有量を以下の方法で測定した。結果を表5に示す。
2,4-ヘプタジエナール標準液(濃度1000ppm,富士フイルム和光純薬(株))を、2,4-ヘプタジエナールの濃度が、10ppb、50ppb、250ppb、500ppbとなるようにしてグリセリン40質量%水溶液(富士フイルム和光純薬(株))を用いて希釈し、検量線作成用試料溶液をそれぞれ調製した。
次いで、各検量線作成用試料溶液1mLを採取してヘッドスペースバイアルに封入して検量線作成用サンプルを調整し、ヘッドスペースガスクロマトグラフ質量分析装置(HS/GC-MS:Head Space - Gas Chromatograph / Mass Spectrometer)を用いて、ピーク面積を測定した。測定装置及び測定条件は以下に示す。
続いて、各検量線作成用サンプルの2,4-ヘプタジエナールの濃度に対して対応するピーク面積をプロットし、検量線を作成した。
HS部:HS-20、(株)島津製作所
GC-MS部:GSMS-QP2020、(株)島津製作所
・ヘッドスペース条件
オーブン温度:80℃
保温時間:30min
・GC/MS条件
カラム:40℃(5min hold)→250℃(15min hold)
スプリット比:10:1
検出:SIMモード(m/z=81)
実施例2B、7B及び比較例1Bの水中油型乳化組成物を、それぞれ1mL採取してヘッドスペースバイアルに封入して各測定サンプルを調整し、(1)で記載した測定装置、測定条件に従って、ヘッドスペースガスクロマトグラフ質量分析装置でピーク面積を測定した。
得られたピーク面積を(1)で作成した検量線に内挿し、各測定サンプル中の2,4-ヘプタジエナールの含有量(A)を求めた。
続いて、式(1)により、濃度1質量%アスタキサンチン含有水中油型乳化物100質量部あたりに換算した2,4-ヘプタジエナールの含有量(B)を求めた。
(B)=(A)/水中油型乳化組成物中のアスタキサンチン含有率・・・式(1)
以下に示すパネル選定用基準を満たす専門パネリストに12名による、実施例2B、実施例7B及び比較例1Bの水中油型乳化組成物の臭気の評価を行った。具体的には、実施例2B、実施例7B及び比較例1Bの各水中油型乳化組成物を室温(25℃)に放置して試料温度を室温に戻した後、専門パネリストに飲用させ、以下の段階で評価し、算術平均した平均値を用いた。
結果を表5に示す。
パネル選定用基準臭[第一薬品産業株式会社]により嗅覚正常者と判断され、かつ、0.4%ショ糖、0.02%クエン酸、0.13%食塩、0.05%グルタミン酸ナトリウム及び0.03 %カフェインの水溶液の味が正しく識別できる者。
藻臭(口に含み、鼻から抜ける藻のような生臭又は魚臭さ)を感じる程度の強さを、比較例1Bを0点として以下の通りにランク付けした。
3点: 非常に強い
2点:強い
1点:少し強い
0点:差がない
-1点:少し弱い
-2点:弱い
-3点:非常に弱い
また、以上の結果から、2,4-ヘプタジエナールの含有量とヒトが感知する臭気の程度には相関性があることが示された。
本明細書に記載された全ての文献、特許出願、および技術規格は、個々の文献、特許出願、および技術規格が参照により取り込まれることが具体的かつ個々に記された場合と同程度に、本明細書中に参照により取り込まれる。
Claims (14)
- アスタキサンチン、油性成分、酵素分解レシチン、ショ糖脂肪酸エステル、水溶性茶抽出物、及び水を含み、
水溶性茶抽出物が、水溶性茶抽出物の全質量に対して茶ポリフェノールを20質量%以上含有し、
水中油型乳化組成物の全質量に対するアスタキサンチンの含有率が0.1質量%~20.0質量%であり、
水中油型乳化組成物の全質量に対する水溶性茶抽出物の含有率が0質量%超20.0質量%以下である、
水中油型乳化組成物。 - さらに、ポリグリセリン脂肪酸エステルを含む、請求項1に記載の水中油型乳化組成物。
- 乳化剤として、ポリグリセリン脂肪酸エステル、ショ糖脂肪酸エステル及び酵素分解レシチンからなる群から選ばれる1種以上のみを含有する、請求項1に記載の水中油型乳化組成物。
- ポリグリセリン脂肪酸エステルを含有し、水中油型乳化組成物の全質量に対するポリグリセリン脂肪酸エステルの含有率が2質量%以上22質量%以下の範囲である、請求項2又は請求項3に記載の水中油型乳化組成物。
- 水溶性茶抽出物が水相に含まれる、請求項1~請求項4のいずれか1項に記載の水中油型乳化組成物。
- ショ糖脂肪酸エステルは、ショ糖脂肪酸エステルの全質量に対するモノ置換体の割合が75質量%以上である、請求項1~請求項5のいずれか1項に記載の水中油型乳化組成物。
- ショ糖脂肪酸エステルを水中油型乳化組成物の全質量に対して0.01質量%以上10質量%以下の範囲で含有する、請求項1~請求項6のいずれか1項に記載の水中油型乳化組成物。
- 酵素分解レシチンを水中油型乳化組成物の全質量に対して0.00001質量%以上7質量%以下の範囲で含有する、請求項1~請求項7のいずれか1項に記載の水中油型乳化組成物。
- さらにグリセリンを水中油型乳化組成物の全質量に対して20質量%以上50質量%以下の範囲で含有する、請求項1~請求項8のいずれか1項に記載の水中油型乳化組成物。
- 前記水溶性茶抽出物が水溶性茶抽出物の全質量に対して茶ポリフェノールを80質量%以上含有する、請求項1~請求項9のいずれか1項に記載の水中油型乳化組成物。
- 油性成分が、中鎖脂肪酸トリグリセライド及び動植物性油脂からなる群より選ばれる少なくとも1種である、請求項1~請求項10のいずれか1項に記載の水中油型乳化組成物。
- 食品添加物用途である、請求項1~請求項11のいずれか1項に記載の水中油型乳化組成物。
- 請求項1~請求項12のいずれか1項に記載の水中油型乳化組成物を含む食品。
- 請求項1~請求項12のいずれか1項に記載の水中油型乳化組成物を含む飲料。
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019545197A JPWO2019066068A1 (ja) | 2017-09-29 | 2018-09-28 | 水中油型乳化組成物、並びに、これを含む食品及び飲料 |
CN201880060938.9A CN111107754A (zh) | 2017-09-29 | 2018-09-28 | 水包油型乳化组合物以及包含其的食品及饮料 |
KR1020207006149A KR102445766B1 (ko) | 2017-09-29 | 2018-09-28 | 수중유형 유화 조성물과, 이것을 포함하는 식품 및 음료 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017-190995 | 2017-09-29 | ||
JP2017190995 | 2017-09-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2019066068A1 true WO2019066068A1 (ja) | 2019-04-04 |
Family
ID=65901974
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2018/036573 WO2019066068A1 (ja) | 2017-09-29 | 2018-09-28 | 水中油型乳化組成物、並びに、これを含む食品及び飲料 |
Country Status (4)
Country | Link |
---|---|
JP (3) | JPWO2019066068A1 (ja) |
KR (1) | KR102445766B1 (ja) |
CN (1) | CN111107754A (ja) |
WO (1) | WO2019066068A1 (ja) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110960492A (zh) * | 2019-12-30 | 2020-04-07 | 福建启元堂生物技术有限公司 | 一种虾青素冻干粉及其制备方法 |
KR20210079443A (ko) * | 2019-12-19 | 2021-06-30 | 주식회사 디네이쳐바이오랩스 | 오메가3 지방산을 포함하는 음료 조성물 및 이의 제조방법 |
WO2021200457A1 (ja) * | 2020-04-02 | 2021-10-07 | サントリーホールディングス株式会社 | 中鎖脂肪酸トリグリセリドとアスコルビン酸とを含有する加熱殺菌済み容器詰め飲料 |
CN114246303A (zh) * | 2021-12-27 | 2022-03-29 | 无锡江大百泰科技有限公司 | 一种用于蛋黄制品的食品添加剂及其制备方法和应用 |
KR102431821B1 (ko) * | 2021-11-22 | 2022-08-12 | 콜마비앤에이치 주식회사 | 오일, 말토덱스트린 및 펙틴을 포함하는 음료 조성물 및 이의 제조방법 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114246332B (zh) * | 2021-12-22 | 2023-08-08 | 无锡江大百泰科技有限公司 | 一种能够增加食品营养保健功效的食品添加剂的制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007275021A (ja) * | 2006-04-11 | 2007-10-25 | Sanei Gen Ffi Inc | ヘマトコッカス藻色素乳化組成物 |
JP2008154577A (ja) * | 2006-12-01 | 2008-07-10 | Fujifilm Corp | エマルション組成物、該エマルション組成物を含む食品及び化粧品 |
JP2008280257A (ja) * | 2007-05-08 | 2008-11-20 | Fujifilm Corp | エマルション組成物及びポリフェノール化合物の凝集防止方法 |
JP2011092083A (ja) * | 2009-10-29 | 2011-05-12 | Fuji Chem Ind Co Ltd | 安定な脂溶性成分含有エマルジョン組成物 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008245588A (ja) * | 2007-03-30 | 2008-10-16 | Nisshin Pharma Inc | 乳化剤組成物及び水中油型エマルジョン |
JP4910927B2 (ja) * | 2007-07-26 | 2012-04-04 | 日油株式会社 | アスタキサンチン含有乳化物、および製造方法 |
CA2950713C (en) * | 2014-08-29 | 2022-07-12 | Fuji Chemical Industries Co., Ltd. | Emulsion composition comprising a lipophilic ingredient |
-
2018
- 2018-09-28 CN CN201880060938.9A patent/CN111107754A/zh active Pending
- 2018-09-28 WO PCT/JP2018/036573 patent/WO2019066068A1/ja active Application Filing
- 2018-09-28 KR KR1020207006149A patent/KR102445766B1/ko active IP Right Grant
- 2018-09-28 JP JP2019545197A patent/JPWO2019066068A1/ja active Pending
-
2021
- 2021-08-16 JP JP2021132191A patent/JP2021177782A/ja active Pending
-
2023
- 2023-04-28 JP JP2023075151A patent/JP2023086983A/ja active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007275021A (ja) * | 2006-04-11 | 2007-10-25 | Sanei Gen Ffi Inc | ヘマトコッカス藻色素乳化組成物 |
JP2008154577A (ja) * | 2006-12-01 | 2008-07-10 | Fujifilm Corp | エマルション組成物、該エマルション組成物を含む食品及び化粧品 |
JP2008280257A (ja) * | 2007-05-08 | 2008-11-20 | Fujifilm Corp | エマルション組成物及びポリフェノール化合物の凝集防止方法 |
JP2011092083A (ja) * | 2009-10-29 | 2011-05-12 | Fuji Chem Ind Co Ltd | 安定な脂溶性成分含有エマルジョン組成物 |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210079443A (ko) * | 2019-12-19 | 2021-06-30 | 주식회사 디네이쳐바이오랩스 | 오메가3 지방산을 포함하는 음료 조성물 및 이의 제조방법 |
KR102359555B1 (ko) * | 2019-12-19 | 2022-02-09 | 주식회사 디네이쳐바이오랩스 | 오메가3 지방산을 포함하는 음료 조성물 및 이의 제조방법 |
CN110960492A (zh) * | 2019-12-30 | 2020-04-07 | 福建启元堂生物技术有限公司 | 一种虾青素冻干粉及其制备方法 |
WO2021200457A1 (ja) * | 2020-04-02 | 2021-10-07 | サントリーホールディングス株式会社 | 中鎖脂肪酸トリグリセリドとアスコルビン酸とを含有する加熱殺菌済み容器詰め飲料 |
CN115397253A (zh) * | 2020-04-02 | 2022-11-25 | 三得利控股株式会社 | 含有中链脂肪酸甘油三酯和抗坏血酸的经加热杀菌的容器装饮料 |
CN115397253B (zh) * | 2020-04-02 | 2023-09-22 | 三得利控股株式会社 | 含有中链脂肪酸甘油三酯和抗坏血酸的经加热杀菌的容器装饮料 |
JP7407643B2 (ja) | 2020-04-02 | 2024-01-04 | サントリーホールディングス株式会社 | 中鎖脂肪酸トリグリセリドとアスコルビン酸とを含有する加熱殺菌済み容器詰め飲料 |
KR102431821B1 (ko) * | 2021-11-22 | 2022-08-12 | 콜마비앤에이치 주식회사 | 오일, 말토덱스트린 및 펙틴을 포함하는 음료 조성물 및 이의 제조방법 |
CN114246303A (zh) * | 2021-12-27 | 2022-03-29 | 无锡江大百泰科技有限公司 | 一种用于蛋黄制品的食品添加剂及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
JP2023086983A (ja) | 2023-06-22 |
KR102445766B1 (ko) | 2022-09-20 |
JP2021177782A (ja) | 2021-11-18 |
KR20200034789A (ko) | 2020-03-31 |
CN111107754A (zh) | 2020-05-05 |
JPWO2019066068A1 (ja) | 2020-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2172223B1 (en) | Composition containing physiologically active substance | |
WO2019066068A1 (ja) | 水中油型乳化組成物、並びに、これを含む食品及び飲料 | |
US8906424B2 (en) | Licorice polyphenol preparation | |
EP2727580B1 (en) | Astaxanthin-containing composition, method for manufacturing same, and cosmetic | |
EP2172196B1 (en) | Composition containing coenzyme q10 | |
JP5256041B2 (ja) | 生理活性物質含有粒子状組成物およびその製造方法 | |
ES2750750T3 (es) | Composición de emulsión | |
JP4869979B2 (ja) | コーヒー豆抽出物含有水性組成物、容器詰飲料、コーヒー豆抽出物含有水性組成物の製造方法、及びコーヒー豆抽出物の沈殿防止方法 | |
JP2009142180A (ja) | 容器詰飲料 | |
JP2009062330A (ja) | 粉末組成物 | |
JP6964660B2 (ja) | 酸化防止剤分散物 | |
JP5631941B2 (ja) | 容器詰飲料 | |
JP5878590B2 (ja) | 容器詰飲料 | |
JP2017186320A (ja) | 乳化組成物及びそれを含むソフトカプセル製剤 | |
US20140141076A1 (en) | Soft capsule preparation, composition for soft capsule preparation, and method of producing soft capsule preparation | |
JP7225374B2 (ja) | 乳化組成物及びこれを含む飲料 | |
JP5283458B2 (ja) | 粉末組成物、食品組成物、化粧品組成物及び医薬品組成物 | |
JP2012040018A (ja) | 容器詰飲料 | |
ES2787229T3 (es) | Composición que contiene coenzima Q10 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18862493 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2019545197 Country of ref document: JP Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 20207006149 Country of ref document: KR Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 18862493 Country of ref document: EP Kind code of ref document: A1 |